NEXTGEN HEALTHCARE, INC. - Quarter Report: 2011 June (Form 10-Q)
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
þ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended June 30, 2011
or
o | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Commission file number: 001-12537
QUALITY SYSTEMS, INC.
(Exact name of registrant as specified in its charter)
California (State or other jurisdiction of incorporation or organization) |
95-2888568 (IRS Employer Identification No.) |
|
18111 Von Karman Avenue, Suite 700, Irvine, California | 92612 | |
(Address of principal executive offices) | (Zip Code) |
(949) 255-2600
(Registrants telephone number, including area code)
(Registrants telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by
Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for
such shorter period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days.
Yes þ No o
Indicate by check mark whether the registrant has submitted electronically and posted on its
corporate Web site, if any, every Interactive Data File required to be submitted and posted
pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months
(or for such shorter period that the registrant was required to submit and post such files).
Yes þ No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer,
or a non-accelerated filer, or a smaller reporting company. See the definitions of large
accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the
Exchange Act.
Large accelerated filer þ
|
Accelerated filer o | Non-accelerated filer o | Small reporting company o | |||
(Do not check if a smaller reporting company) |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the
Exchange Act).
Yes o No þ
The number of outstanding shares of the Registrants common stock as of July 29, 2011 was
29,296,390 shares.
QUALITY SYSTEMS, INC.
TABLE OF CONTENTS
FORM 10-Q
FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2011
FORM 10-Q
FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2011
Table of Contents
PART I. FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
QUALITY SYSTEMS, INC.
CONSOLIDATED BALANCE SHEETS
(In thousands, except per share data)
(unaudited)
June 30, | March 31, | |||||||
2011 | 2011 | |||||||
ASSETS |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ | 124,054 | $ | 116,617 | ||||
Restricted cash |
4,487 | 3,787 | ||||||
Marketable securities |
1,110 | 1,120 | ||||||
Accounts receivable, net |
148,907 | 139,772 | ||||||
Inventories |
2,145 | 1,933 | ||||||
Deferred income taxes, net |
10,397 | 10,397 | ||||||
Other current assets |
8,232 | 8,768 | ||||||
Total current assets |
299,332 | 282,394 | ||||||
Equipment and improvements, net |
13,778 | 12,599 | ||||||
Capitalized software costs, net |
15,738 | 15,150 | ||||||
Intangibles, net |
17,919 | 16,890 | ||||||
Goodwill |
48,624 | 46,721 | ||||||
Other assets |
4,892 | 4,932 | ||||||
Total assets |
$ | 400,283 | $ | 378,686 | ||||
LIABILITIES AND SHAREHOLDERS EQUITY |
||||||||
Current liabilities: |
||||||||
Accounts payable |
$ | 6,145 | $ | 6,686 | ||||
Deferred revenue |
80,027 | 76,695 | ||||||
Accrued compensation and related benefits |
9,901 | 10,247 | ||||||
Income taxes payable |
7,889 | 3,530 | ||||||
Dividends payable |
10,229 | 10,162 | ||||||
Other current liabilities |
17,368 | 29,316 | ||||||
Total current liabilities |
131,559 | 136,636 | ||||||
Deferred revenue, net of current |
1,106 | 1,099 | ||||||
Deferred income taxes, net |
11,384 | 11,384 | ||||||
Deferred compensation |
2,784 | 2,488 | ||||||
Other noncurrent liabilities |
2,918 | 2,409 | ||||||
Total liabilities |
149,751 | 154,016 | ||||||
Commitments and contingencies (Note 12) |
||||||||
Shareholders equity: |
||||||||
Common stock |
||||||||
$0.01 par value; authorized 50,000 shares; issued
and outstanding 29,264 and 29,034 shares at
June 30, 2011 and March 31, 2011, respectively |
292 | 290 | ||||||
Additional paid-in capital |
150,363 | 133,259 | ||||||
Retained earnings |
99,877 | 91,121 | ||||||
Total shareholders equity |
250,532 | 224,670 | ||||||
Total liabilities and shareholders equity |
$ | 400,283 | $ | 378,686 | ||||
The accompanying notes are an integral part of these consolidated financial statements.
3
Table of Contents
QUALITY SYSTEMS, INC.
CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except per share data)
(unaudited)
Three Months Ended June 30, | ||||||||
2011 | 2010 | |||||||
Revenues: |
||||||||
Software, hardware and supplies |
$ | 28,911 | $ | 24,756 | ||||
Implementation and training services |
5,472 | 4,308 | ||||||
System sales |
34,383 | 29,064 | ||||||
Maintenance |
31,502 | 25,536 | ||||||
Electronic data interchange services |
12,092 | 9,764 | ||||||
Revenue cycle management and related services |
11,881 | 10,772 | ||||||
Other services |
10,584 | 7,791 | ||||||
Maintenance, EDI, RCM and other services |
66,059 | 53,863 | ||||||
Total revenues |
100,442 | 82,927 | ||||||
Cost of revenue: |
||||||||
Software, hardware and supplies |
4,614 | 6,212 | ||||||
Implementation and training services |
4,075 | 2,990 | ||||||
Total cost of system sales |
8,689 | 9,202 | ||||||
Maintenance |
3,854 | 3,454 | ||||||
Electronic data interchange services |
7,962 | 6,709 | ||||||
Revenue cycle management and related services |
8,826 | 8,145 | ||||||
Other services |
5,597 | 4,349 | ||||||
Total cost of maintenance, EDI, RCM and other services |
26,239 | 22,657 | ||||||
Total cost of revenue |
34,928 | 31,859 | ||||||
Gross profit |
65,514 | 51,068 | ||||||
Operating expenses: |
||||||||
Selling, general and administrative |
29,386 | 26,238 | ||||||
Research and development costs |
6,827 | 5,456 | ||||||
Amortization of acquired intangible assets |
482 | 347 | ||||||
Total operating expenses |
36,695 | 32,041 | ||||||
Income from operations |
28,819 | 19,027 | ||||||
Interest income |
82 | 60 | ||||||
Other expense, net |
(38 | ) | (6 | ) | ||||
Income before provision for income taxes |
28,863 | 19,081 | ||||||
Provision for income taxes |
9,880 | 6,989 | ||||||
Net income |
$ | 18,983 | $ | 12,092 | ||||
Net income per share: |
||||||||
Basic |
$ | 0.65 | $ | 0.42 | ||||
Diluted |
$ | 0.65 | $ | 0.42 | ||||
Weighted-average shares outstanding: |
||||||||
Basic |
29,181 | 28,896 | ||||||
Diluted |
29,400 | 29,057 | ||||||
Dividends declared per common share |
$ | 0.35 | $ | 0.30 |
The accompanying notes are an integral part of these consolidated financial statements.
4
Table of Contents
QUALITY SYSTEMS, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)
Three Months Ended June 30, | ||||||||
2011 | 2010 | |||||||
Cash flows from operating activities: |
||||||||
Net income |
$ | 18,983 | $ | 12,092 | ||||
Adjustments to reconcile net income to net cash provided
by operating activities: |
||||||||
Depreciation |
1,244 | 962 | ||||||
Amortization of capitalized software costs |
1,925 | 1,669 | ||||||
Amortization of other intangibles |
901 | 765 | ||||||
Provision for bad debts |
980 | 850 | ||||||
Share-based compensation |
956 | 1,065 | ||||||
Deferred income tax benefit |
| (262 | ) | |||||
Tax benefit associated with stock options |
852 | 175 | ||||||
Excess tax benefit from share-based compensation |
(852 | ) | (175 | ) | ||||
Changes in assets and liabilities, net of amounts acquired: |
||||||||
Accounts receivable |
(9,651 | ) | (4,924 | ) | ||||
Inventories |
(212 | ) | (53 | ) | ||||
Income taxes receivable |
| 2,953 | ||||||
Other current assets |
57 | 278 | ||||||
Other assets |
40 | (323 | ) | |||||
Accounts payable |
(571 | ) | 1,181 | |||||
Deferred revenue |
3,245 | (214 | ) | |||||
Accrued compensation and related benefits |
(346 | ) | (1,355 | ) | ||||
Income taxes payable |
4,359 | 3,843 | ||||||
Other current liabilities |
(1,182 | ) | 721 | |||||
Deferred compensation |
296 | 71 | ||||||
Other noncurrent liabilities |
509 | 47 | ||||||
Net cash provided by operating activities |
21,533 | 19,366 | ||||||
Cash flows from investing activities: |
||||||||
Additions to capitalized software costs |
(2,513 | ) | (2,545 | ) | ||||
Additions to equipment and improvements |
(2,423 | ) | (878 | ) | ||||
Purchase of IntraNexus |
(3,279 | ) | | |||||
Net cash used in investing activities |
(8,215 | ) | (3,423 | ) | ||||
Cash flows from financing activities: |
||||||||
Excess tax benefit from share-based compensation |
852 | 175 | ||||||
Proceeds from exercise of stock options |
3,427 | 1,144 | ||||||
Dividends paid |
(10,160 | ) | (8,665 | ) | ||||
Net cash used in financing activities |
(5,881 | ) | (7,346 | ) | ||||
Net increase in cash and cash equivalents |
7,437 | 8,597 | ||||||
Cash and cash equivalents at beginning of period |
116,617 | 84,611 | ||||||
Cash and cash equivalents at end of period |
$ | 124,054 | $ | 93,208 | ||||
5
Table of Contents
QUALITY SYSTEMS, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS (Continued)
(In thousands)
CONSOLIDATED STATEMENTS OF CASH FLOWS (Continued)
(In thousands)
(Unaudited)
Three Months Ended June 30, | ||||||||
2011 | 2010 | |||||||
Supplemental disclosures of cash flow information: |
||||||||
Cash paid during the period for income taxes, net of
refunds |
$ | 4,668 | $ | 276 | ||||
Non-cash investing and financing activities: |
||||||||
Unrealized loss on marketable securities, net of tax |
$ | (10 | ) | $ | | |||
Common stock issued at fair value for Opus earnout
settlement |
$ | 11,887 | $ | | ||||
Effective April 29, 2011, the Company acquired IntraNexus in a transaction summarized as follows: |
||||||||
Fair value of net assets acquired |
$ | 4,524 | ||||||
Cash paid |
(3,279 | ) | ||||||
Purchase price holdback |
(125 | ) | ||||||
Fair value of contingent consideration |
(800 | ) | ||||||
Liabilities assumed |
$ | 320 | ||||||
The accompanying notes are an integral part of these consolidated financial statements.
6
Table of Contents
QUALITY SYSTEMS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except shares and per share data)
(Unaudited)
1. Summary of Significant Accounting Policies
Principles of Consolidation. The consolidated financial statements include the accounts of Quality
Systems, Inc. and its wholly-owned subsidiaries, which consists of NextGen Healthcare Information
Systems (NextGen), Lackland Acquisition II, LLC dba Healthcare Strategic Initiatives (HSI),
Practice Management Partners, Inc. (PMP), NextGen Inpatient Solutions, LLC (NextGen IS f/k/a
Sphere), Opus Healthcare Solutions, LLC (Opus), IntraNexus, Inc. (IntraNexus) and Quality
Systems India Healthcare Private Limited (QSIH) (collectively, the Company). All intercompany
accounts and transactions have been eliminated.
Business Segments. The Company has prepared operating segment information in accordance with
Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 280,
Segment Reporting, or ASC 280, which requires that companies disclose operating segments based on
the manner in which management disaggregates the Companys operations for making internal operating
decisions. See Note 13.
Basis of Presentation. The accompanying unaudited consolidated financial statements as of June 30,
2011 and for the three months ended June 30, 2011 and 2010 have been prepared in accordance with
the requirements of Form 10-Q and Article 10 of Regulation S-X and therefore do not include all
information and notes which would be presented were such consolidated financial statements prepared
in accordance with accounting principles generally accepted in the United States of America
(GAAP). These consolidated financial statements should be read in conjunction with the audited
consolidated financial statements presented in the Companys Annual Report on Form 10-K for the
fiscal year ended March 31, 2011. Amounts related to disclosures of March 31, 2011 balances within
these interim consolidated financial statements were derived from the aforementioned Form 10-K. In
the opinion of management, the accompanying consolidated financial statements reflect all
adjustments which are necessary for a fair presentation of the results of operations and cash flows
for the periods presented. The results of operations for such interim periods are not necessarily
indicative of results of operations to be expected for the full year.
Certain prior period amounts have been reclassified to conform with fiscal year 2012 presentation.
References to amounts in the consolidated financial statement sections are in thousands, except
shares and per share data, unless otherwise specified.
Revenue Recognition. The Company recognizes revenue for system sales pursuant to FASB ASC Topic
985-605, Software, Revenue Recognition, or ASC 985-605. The Company generates revenue from the
sale of licensing rights to its software products directly to end-users and value-added resellers,
or VARs. The Company also generates revenue from sales of hardware and third-party software,
implementation, training, electronic data interchange (EDI), post-contract support (maintenance)
and other services, including revenue cycle management (RCM), performed for clients who license
its products.
A typical system contract contains multiple elements of the above items. FASB ASC Topic
985-605-25, Software, Revenue Recognition, Multiple Elements, or ASC 985-605-25, requires revenue
earned on software arrangements involving multiple elements to be allocated to each element based
on the relative fair values of those elements. The fair value of an element must be based on
vendor-specific objective evidence (VSOE). The Company limits its assessment of VSOE for each
element to either the price charged when the same element is sold separately or the price
established by management having the relevant authority to do so, for an element not yet sold
separately. VSOE calculations are updated and reviewed quarterly or annually depending on the
nature of the product or service. The Company has established VSOE for the related undelivered
elements based on the bell-shaped curve method. Maintenance VSOE for the Companys largest clients
is based on stated renewal rates only if the rate is determined to be substantive and falls within
the Companys customary pricing practices.
When evidence of fair value exists for the delivered and undelivered elements of a transaction,
then discounts for individual elements are aggregated and the total discount is allocated to the
individual elements in proportion to the elements fair value relative to the total contract fair
value.
When evidence of fair value exists for the undelivered elements only, the residual method, provided
for under ASC 985-605, is used. Under the residual method, the Company defers revenue related to
the undelivered elements in a system sale based on VSOE of fair value of each of the undelivered
elements and allocates the remainder of the contract price net of all discounts to revenue
recognized from the delivered elements. If VSOE of fair value of any undelivered element does not
exist, all revenue is deferred until VSOE of fair value of the undelivered element is established
or the element has been delivered.
The Company bills for the entire system sales contract amount upon contract execution except for
maintenance which is billed separately. Amounts billed in excess of the amounts contractually due
are recorded in accounts receivable as advance billings. Amounts are contractually due when
services are performed or in accordance with contractually specified payment dates. Provided the
fees are fixed or determinable and collection is considered probable, revenue from licensing rights
and sales of hardware and third-party software is generally recognized upon physical or electronic
shipment and transfer of title. In certain transactions where collection risk is high, the cash
basis method is used to recognize revenue. If the fee is not fixed or determinable, then the
revenue recognized in each period (subject to application of other revenue
7
Table of Contents
recognition criteria) will be the lesser of the aggregate of amounts due and payable or the amount
of the arrangement fee that would have been recognized if the fees were being recognized using the
residual method. Fees which are considered fixed or determinable at the inception of the Companys
arrangements must include the following characteristics:
§ | The fee must be negotiated at the outset of an arrangement and generally be based on the specific volume of products to be delivered without being subject to change based on variable pricing mechanisms such as the number of units copied or distributed or the expected number of users. | |
§ | Payment terms must not be considered extended. If a significant portion of the fee is due more than 12 months after delivery or after the expiration of the license, the fee is presumed not fixed or determinable. |
Revenue from implementation and training services is recognized as the corresponding services are
performed. Maintenance revenue is recognized ratably over the contractual maintenance period.
Product returns are estimated in accordance with FASB ASC Topic 605-15, Revenue Recognition,
Products, or ASC 605-15. The Company also ensures that the other criteria in ASC 605-15 have been
met prior to recognition of revenue:
§ | the price is fixed or determinable; | |
§ | the customer is obligated to pay and there are no contingencies surrounding the obligation or the payment; | |
§ | the customers obligation would not change in the event of theft or damage to the product; | |
§ | the customer has economic substance; | |
§ | the amount of returns can be reasonably estimated; and | |
§ | the Company does not have significant obligations for future performance in order to bring about resale of the product by the customer. |
The Company has historically offered short-term rights of return in certain sales arrangements. If
the Company is able to estimate returns for these types of arrangements, revenue is recognized, net
of an allowance for returns, and these arrangements are recorded in the consolidated financial
statements. If the Company is unable to estimate returns for these types of arrangements, revenue
is not recognized in the consolidated financial statements until the rights of return expire.
Revenue related to sales arrangements that include the right to use software stored on the
Companys hardware is accounted for under FASB ASC Topic 985-605-05, Software, Revenue Recognition,
Hosting Arrangements, or ASC 985-605-05, which requires that for software licenses and related
implementation services to continue to fall under ASC 985-605-05, the customer must have the
contractual right to take possession of the software without incurring a significant penalty and it
must be feasible for the customer to either host the software themselves or through another
third-party. If an arrangement is not deemed to be accounted for under ASC 985-605-05, the entire
arrangement is accounted for as a service contract in accordance with ASC 985-605-25. In that
instance, the entire arrangement would be recognized during the period that the hosting services
are being performed.
From time to time, the Company offers future purchase discounts on its products and services as
part of its sales arrangements. Pursuant to FASB ASC Topic 985-605-55, Software, Revenue
Recognition, Flowchart of Revenue Recognition on Software Arrangements, or ASC 985-605-55, such
discounts that are incremental to the range of discounts reflected in the pricing of the other
elements of the arrangement, that are incremental to the range of discounts typically given in
comparable transactions, and that are significant, are treated as an additional element of the
contract to be deferred. Amounts deferred related to future purchase options are not recognized
until either the customer exercises the discount offer or the offer expires.
RCM service revenue is derived from services fees, which include amounts charged for ongoing
billing and other related services, and are generally billed to the customer as a percentage of
total collections. The Company does not recognize revenue for services fees until these
collections are made, as the services fees are not fixed or determinable until such time.
Revenue is divided into two categories, system sales and maintenance, EDI, RCM and other
services. Revenue in the system sales category includes software license fees, third-party
hardware and software and implementation and training services related to purchase of the Companys
software systems. Revenue in the maintenance, EDI, RCM and other services category includes
maintenance, EDI, RCM services, follow on training and implementation services, annual third-party
license fees, hosting services and other services revenue.
Cash and Cash Equivalents. Cash and cash equivalents generally consist of cash, money market funds
and short-term U.S. Treasury securities with maturities of 90 days or less at the time of purchase.
The money market fund in which the Company holds a portion of its cash invests in only investment
grade money market instruments from a variety of industries, and therefore bears relatively low
market risk. The average maturity of the investments owned by the money market fund is
approximately two months.
Restricted Cash. Restricted cash consists of cash which is being held by HSI acting as agent for
the disbursement of certain state social services programs. The Company records an offsetting
Care Services liability (see also Note 7) when it initially receives such cash from the
government social service programs and relieves both restricted cash and the Care Services
liability when amounts are disbursed. HSI earns an administrative fee which is based on a
percentage of funds disbursed on behalf of certain government social service programs.
8
Table of Contents
Marketable Securities. Marketable securities are classified as available-for-sale and are recorded
at fair value, based on quoted market rates when observable or valuation analysis when appropriate.
Unrealized gains and losses, net of taxes, are reported as a component of shareholders equity.
Realized gains and losses on investments are included as interest income.
The Companys marketable securities consist of fixed-income municipal securities. Unrealized
losses as of June 30, 2011 were $10, and unrealized losses as of March 31, 2011 were not
significant.
Allowance for Doubtful Accounts. The Company provides credit terms typically ranging from thirty
days to less than twelve months for most system and maintenance contract sales and generally does
not require collateral. The Company performs credit evaluations of its clients and maintains
reserves for estimated credit losses. Reserves for potential credit losses are determined by
establishing both specific and general reserves. Specific reserves are based on managements
estimate of the probability of collection for certain troubled accounts. General reserves are
established based on the Companys historical experience of bad debt expense and the aging of the
Companys accounts receivable balances, net of deferred revenue and specifically reserved accounts.
Accounts are written off as uncollectible only after the Company has expended extensive collection
efforts.
Included in accounts receivable are amounts related to maintenance and services which were billed,
but which had not yet been rendered as of the end of the period. Undelivered maintenance and
services are included as a component of deferred revenue (see also Note 7).
Equipment and Improvements. Equipment and improvements are stated at cost less accumulated
depreciation and amortization. Repair and maintenance costs that do not improve service potential
or extend economic life are expensed as incurred. Depreciation and amortization of equipment and
improvements are provided over the estimated useful lives of the assets, or the related lease terms
if shorter, by the straight-line method. Useful lives generally have the following ranges:
Computers equipment
|
3-5 years | |
Furniture and fixtures
|
5-7 years | |
Leasehold improvements
|
lesser of lease term or estimated useful life of asset |
Costs incurred to develop internal-use software during the application development stage are
capitalized, stated at cost, and amortized using the straight-line method over the estimated useful
lives of the assets, which is seven years. Application development stage costs generally include
costs associated with internal-use software configuration, coding, installation and testing. Costs
of significant upgrades and enhancements that result in additional functionality are also
capitalized, whereas costs incurred for maintenance and minor upgrades and enhancements are
expensed as incurred.
Software Development Costs. Development costs incurred in the research and development of new
software products and enhancements to existing software products for external use are expensed as
incurred until technological feasibility has been established. After technological feasibility is
established, any additional external software development costs are capitalized in accordance with
FASB ASC Topic 985-20, Software, Costs of Computer Software to be Sold, Leased or Marketed, or ASC
985-20. Such capitalized costs are amortized on a straight-line basis over the estimated economic
life of the related product, which is typically three years. The Company provides support services
on the current and prior two versions of its software. Management performs an annual review of the
estimated economic life and the recoverability of such capitalized software costs. If a
determination is made that capitalized amounts are not recoverable based on the estimated cash
flows to be generated from the applicable software, any remaining capitalized amounts are written
off.
Goodwill. Goodwill is related to NextGen and the HSI, PMP, NextGen IS, Opus and IntraNexus
acquisitions (see Notes 3 and 4). In accordance with FASB ASC Topic 350-20, Intangibles Goodwill
and Other, Goodwill, or ASC 350-20, the Company tests goodwill for impairment annually at the end
of its first fiscal quarter, referred to as the annual test date. The Company will also test for
impairment between annual test dates if an event occurs or circumstances change that would indicate
the carrying amount may be impaired. Impairment testing for goodwill is performed at a
reporting-unit level, which is defined as an operating segment or one level below an operating
segment (referred to as a component). A component of an operating segment is a reporting unit if
the component constitutes a business for which discrete financial information is available and
segment management regularly reviews the operating results of that component.
The Company has determined that NextGen qualifies as a separate reporting unit while HSI and PMP
are aggregated as one reporting unit (the Practice Solutions Division) and NextGen IS, Opus and
IntraNexus are aggregated as a separate reporting unit (the Inpatient Solutions Division) for which
goodwill impairment testing is performed.
Determining the fair value of a reporting unit involves the use of significant estimates and
assumptions. The estimate of fair value of each of the Companys reporting units is based on the
projection of revenues, cost of services, other expenses and cash flows considering historical and
estimated future results, general economic and market conditions as well as the impact of planned
business and operational strategies. The Company determines its fair value estimates using
assumptions it believes to be reasonable at the time; however, such assumptions are subject to
inherent uncertainty. Actual results may differ from those estimates. The valuations employ
present value techniques to measure fair value and consider market factors.
9
Table of Contents
For the Practice Solutions Division and Inpatient Solutions Division, fair value was determined
based upon a combination of various valuation techniques, including an income approach, which
utilizes discounted future cash flow projections based upon managements five-year forecasts, a
market approach, which is based upon pricing multiples at which similar companies have been sold
and a cost approach where an analysis of assets and liabilities is performed to restate each to
fair value, then determining enterprise value from the difference between current assets and
current liabilities. Key assumptions used to determine the fair value of each reporting unit as of
the Companys annual assessment date are as follows: (a) expected cash flow for the period from
2012 to 2017 plus a terminal year; (b) a discount rate ranging from 15.0% to 19.0% for the Practice
Solutions Division and Inpatient Solutions Division, which are based on marketplace participant
expectations; and (c) a debt-free net cash flow long-term growth rate of between 3% and 5%, which
is based on expected levels of growth for nominal GDP and inflation.
The estimated fair value of NextGen was determined using an estimate of future cash flows over both
five and ten year periods and risk adjusted discount rates of between 10% and 25% to compute a net
present value of discounted future cash flows.
An impairment loss would generally be recognized when the carrying amount of the reporting units
net assets exceeds the estimated fair value of the reporting unit. Based on its analysis, the
Company has determined that there was no impairment to its goodwill as of June 30, 2011. See Note
4.
Intangible Assets. Intangible assets consist of capitalized software costs, customer
relationships, trade names and certain software technology. Intangible assets related to customer
relationships, trade names, and software technology arose in connection with the acquisitions of
HSI, PMP, NextGen IS, Opus and IntraNexus. These intangible assets were recorded at fair value and
are stated net of accumulated amortization. Intangible assets are amortized over their remaining
estimated useful lives, ranging from 3 to 9 years. The Companys amortization policy for
intangible assets is based on the principles in FASB ASC Topic 350-30, Intangibles Goodwill and
Other, General Intangibles Other than Goodwill, or ASC 350-30, which requires that the amortization
of intangible assets reflect the pattern that the economic benefits of the intangible assets are
consumed.
Income Taxes. The Company accounts for income taxes in accordance with FASB ASC Topic 740, Income
Taxes, or ASC 740. Income taxes are provided based on current taxable income and the future tax
consequences of temporary differences between the basis of assets and liabilities for financial and
tax reporting. The deferred income tax assets and liabilities represent the future state and
federal tax return consequences of those differences, which will either be taxable or deductible
when the assets and liabilities are recovered or settled. Deferred income taxes are also
recognized for operating losses that are available to offset future taxable income and tax credits
that are available to offset future income taxes. At each reporting period, management assesses
the realizable value of deferred tax assets based on, among other things, estimates of future
taxable income and adjusts the related valuation allowance as necessary. Management makes a number
of assumptions and estimates in determining the appropriate amount of expense to record for income
taxes. These assumptions and estimates consider the taxing jurisdiction in which the Company
operates as well as current tax regulations. Accruals are established for estimates of tax effects
for certain transactions and future projected profitability of the Companys businesses based on
managements interpretation of existing facts and circumstances.
Self-Insurance Liabilities. Effective January 1, 2010, the Company became self-insured with
respect to healthcare claims, subject to stop-loss limits. The Company accrues for estimated
self-insurance costs and uninsured exposures based on claims filed and an estimate of claims
incurred but not reported as of each balance sheet date. However, it is possible that recorded
accruals may not be adequate to cover the future payment of claims. Adjustments, if any, to
estimated accruals resulting from ultimate claim payments will be reflected in earnings during the
periods in which such adjustments are determined. Periodically, the Company reevaluates the
adequacy of the accruals by comparing amounts accrued on the balance sheets for anticipated losses
to an updated actuarial loss forecasts and third-party claim administrator loss estimates and makes
adjustments to the accruals as needed. The self-insurance accrual is included in other current
liabilities. If any of the factors that contribute to the overall cost of insurance claims were to
change, the actual amount incurred for the self-insurance liabilities would be directly affected.
Foreign Currency Translation. The U.S. dollar is considered to be the functional currency for QSIH
because it acts primarily as an extension of the Companys operations. The determination of
functional currency is primarily based on QSIHs relative financial and operational dependence.
Assets and liabilities are re-measured at current exchange rates, except for property and
equipment, depreciation and investments, which are translated at historical exchange rates.
Revenues and expenses are re-measured at weighted average exchange rates in effect during the year
except for costs related to the above mentioned balance sheet items, which are translated at
historical rates. Any resulting foreign currency translation adjustments are reported as a
component of shareholders equity. The cumulative foreign currency translation adjustment as June
30, 2011 and March 31, 2011 was not significant. Foreign currency gains and losses are included in
other expense in the consolidated statements of income. The net foreign currency loss for
the three months ended June 30, 2011 was not significant.
Share-Based Compensation. FASB ASC Topic 718 Compensation Stock Compensation, or ASC 718,
requires companies to estimate the fair value of share-based payment awards on the date of grant
using an option-pricing model. Expected term is estimated using historical exercise experience.
Volatility is estimated using the weighted-average historical volatility of the Companys common
stock, which approximates expected volatility. The risk free rate is the implied yield available
on the U.S Treasury zero-coupon issues with remaining terms equal to the expected term. The
expected dividend yield is the average dividend rate during a period equal to the expected term of
the option. Those inputs are then entered into the Black Scholes model to determine the estimated
fair value. The value of the portion of the award that is ultimately expected to vest is
recognized ratably as expense over the requisite service period in the Companys consolidated
statements of income.
10
Table of Contents
Share-based compensation is adjusted on a quarterly basis for changes to estimated forfeitures
based on a review of historical forfeiture activity. To the extent that actual forfeitures differ,
or are expected to differ, from the estimate, share-based compensation expense is adjusted
accordingly. The effect of the forfeiture adjustments for three months ended June 30, 2011 and
2010 was not significant.
The following table shows total share-based compensation expense included in the consolidated
statements of income for three months ended June 30, 2011 and 2010:
Three Months Ended June 30, | ||||||||
2011 | 2010 | |||||||
Costs and expenses: |
||||||||
Cost of revenue |
$ | 49 | $ | 68 | ||||
Research and development costs |
33 | 28 | ||||||
Selling, general and administrative |
874 | 969 | ||||||
Total share-based compensation |
956 | 1,065 | ||||||
Amounts capitalized in software development costs |
| (1 | ) | |||||
Amounts charged against earnings, before income tax benefit |
$ | 956 | $ | 1,064 | ||||
Related income tax benefit |
(358 | ) | (348 | ) | ||||
Decrease in net income |
$ | 598 | $ | 716 | ||||
Recent Accounting Standards. In April 2010, FASB issued an amendment to stock compensation. The
amendment clarifies that an employee stock-based payment award with an exercise price denominated
in the currency of a market in which a substantial portion of the entitys equity shares trades
should not be considered to contain a condition that is not a market, performance, or service
condition. Therefore, an entity would not classify such an award as a liability if it otherwise
qualifies as equity. The amendments are effective for fiscal years, and interim periods within
those fiscal years, beginning on or after December 15, 2010. There was no material impact from the
adoption of this guidance on the Companys consolidated financial position or results of operations since the Companys
stock-based payment awards have an exercise price denominated in the same currency of the market in
which the Companys shares are traded.
In December 2010, FASB issued an amendment to goodwill impairment test. The amendments modify Step
1 of the goodwill impairment test for reporting units with zero or negative carrying amounts. For
those reporting units, an entity is required to perform Step 2 of the goodwill impairment test if
it is more likely than not that a goodwill impairment exists. In determining whether it is more
likely than not that goodwill impairment exists, an entity should consider whether there are any
adverse qualitative factors indicating that impairment may exist. The qualitative factors are
consistent with the existing guidance and examples, which require that goodwill of a reporting unit
be tested for impairment between annual tests if an event occurs or circumstances change that would
more likely than not reduce the fair value of a reporting unit below its carrying amount. The
amendments are effective for fiscal years, and interim periods within those years, beginning after
December 15, 2010. There was no material impact from the adoption of this guidance on the Companys
consolidated financial position or results of operations since the Company does not have any reporting units
with zero or negative carrying amounts.
In December 2010, FASB issued an amendment to the disclosure of supplementary pro forma information
for business combinations. The amendments in this ASU specify that if a public entity presents
comparative financial statements, the entity should disclose revenue and earnings of the combined
entity as though the business combination that occurred during the current year had occurred as of
the beginning of the comparable prior annual reporting period only. The amendments also expand the
supplemental pro forma disclosures to include a description of the nature and amount of material,
nonrecurring pro forma adjustments directly attributable to the business combination included in
the reported pro forma revenue and earnings. The amendments are effective prospectively for
business combinations for which the acquisition date is on or after the beginning of the first
annual reporting period beginning on or after December 15, 2010. The adoption of this guidance had
no material impact on the Companys consolidated financial position or results of operations but may have an effect on the required disclosures for future business combinations.
11
Table of Contents
2. Fair Value Measurements
The Company applies ASC 820 with respect to fair value measurements of (a) nonfinancial assets and
liabilities that are recognized or disclosed at fair value and (b) all financial assets and
liabilities. As defined by ASC 820, fair value is the price that would be received to sell an
asset or paid to transfer a liability (an exit price) in the principal or most advantageous market
for the asset or liability in an orderly transaction between market participants on the measurement
date. The Company estimates fair value utilizing market data or assumptions that market
participants would use in pricing the asset or liability in a current transaction, including
assumptions about risk and the risks inherent in the inputs to the valuation technique. The
Companys financial instruments, other than those presented in the disclosures below, include
accounts receivables, accounts payable and accrued liabilities. The carrying value of these assets
and liabilities approximates fair value because of the short-term nature of these instruments. ASC
820 prioritizes the inputs used in measuring fair value into the following hierarchy (with Level 1
as the highest priority):
Level 1
|
Quoted market prices in active markets for identical assets or liabilities; | |
Level 2
|
Observable inputs other than those included in Level 1 (for example, quoted prices for similar assets in active markets or quoted prices for identical assets in inactive markets); and | |
Level 3
|
Unobservable inputs reflecting managements own assumptions about the inputs used in estimating the value of the asset. |
Recurring Fair Value Measurements
The fair value hierarchy requires the use of observable market data when available. The financial
assets and liabilities are classified in their entirety based on the lowest level of input that is
significant to the fair value measurement. The Companys assessment of the significance of a
particular input to the fair value measurement requires judgment and may affect the valuation of
fair value assets and liabilities and their placement within the fair value hierarchy levels. The
following tables sets forth by level within the fair value hierarchy the Companys financial assets
and liabilities that were accounted for at fair value on a recurring basis at June 30, 2011 and
March 31, 2011:
Quoted Prices | ||||||||||||||||
in Active | Significant | |||||||||||||||
Markets for | Other | |||||||||||||||
Balance at | Identical | Observable | Unobservable | |||||||||||||
June 30, | Assets | Inputs | Inputs | |||||||||||||
2011 | (Level 1) | (Level 2) | (Level 3) | |||||||||||||
ASSETS |
||||||||||||||||
Cash and cash equivalents (1) |
$ | 124,054 | $ | 124,054 | $ | | $ | | ||||||||
Restricted cash |
4,487 | 4,487 | | | ||||||||||||
Marketable securities (2) |
1,110 | 1,110 | | | ||||||||||||
$ | 129,651 | $ | 129,651 | $ | | $ | | |||||||||
LIABILITIES |
||||||||||||||||
Contingent consideration related to acquisitions |
$ | 1,616 | $ | | $ | | $ | 1,616 | ||||||||
$ | 1,616 | $ | | $ | | $ | 1,616 | |||||||||
(1) | Cash and cash equivalents consists of money market funds and certificates of deposit. | |
(2) | Marketable securities consists of municipal fixed-income municipal securities. |
12
Table of Contents
Quoted Prices | ||||||||||||||||
in Active | Significant | |||||||||||||||
Markets for | Other | |||||||||||||||
Balance at | Identical | Observable | Unobservable | |||||||||||||
March 31, | Assets | Inputs | Inputs | |||||||||||||
2011 | (Level 1) | (Level 2) | (Level 3) | |||||||||||||
ASSETS |
||||||||||||||||
Cash and cash equivalents (1) |
$ | 116,617 | $ | 116,617 | $ | | $ | | ||||||||
Restricted cash |
3,787 | 3,787 | | | ||||||||||||
Marketable securities (2) |
1,120 | 1,120 | | | ||||||||||||
$ | 121,524 | $ | 121,524 | $ | | $ | | |||||||||
LIABILITIES |
||||||||||||||||
Contingent consideration related to acquisitions |
$ | 13,658 | $ | | $ | 12,743 | $ | 915 | ||||||||
$ | 13,658 | $ | | $ | 12,743 | $ | 915 | |||||||||
(1) | Cash and cash equivalents consists of money market funds and certificates of deposit. | |
(2) | Marketable securities consists of municipal fixed-income municipal securities. |
The Companys contingent consideration liability is accounted for at fair value on a recurring
basis and is adjusted to fair value when the carrying value differs from fair value. The
categorization of the framework used to measure fair value of the contingent consideration
liability is considered Level 3 due to the subjective nature of the unobservable inputs used. The
fair values of the contingent consideration liability were $816 for NextGen IS and $800 for
IntraNexus, which were estimated based on the probability of achieving certain business milestones
and managements forecast of expected revenues. See Note 3.
The following table presents activity in the Companys financial assets and liabilities measured at
fair value using significant unobservable inputs (Level 3), as defined by ASC 820, as of and for
the three months ended June 30, 2011:
Liabilities | ||||
Balance at April 1, 2011 |
$ | 915 | ||
Acquisition (Note 3) |
800 | |||
Earnout payments |
(99 | ) | ||
Balance at June 30, 2011 |
$ | 1,616 | ||
Non-Recurring Fair Value Measurements
The Company has certain assets, including goodwill and other intangible assets, which are measured
at fair value on a non-recurring basis and are adjusted to fair value only if an impairment charge
is recognized. The categorization of the framework used to measure fair value of the assets is
considered Level 3 due to the subjective nature of the unobservable inputs used. During the three
months ended June 30, 2011, there were no adjustments to fair value of such assets.
Fair Value of Financial Instruments
The estimated fair value of financial instruments is determined using the best available market
information and appropriate valuation methodologies. However, considerable judgment is necessary
in interpreting market data to develop the estimates of fair value. Accordingly, the estimates
presented are not necessarily indicative of the amounts that the Company could realize in a current
market exchange, or the value that ultimately will be realized upon maturity or disposition. The
use of different market assumptions may have a material effect on the estimated fair value amounts.
The Companys financial instruments, other than those presented in the disclosures above, include
accounts receivables, accounts payable and accrued liabilities. The carrying value of these assets
and liabilities approximates fair value because of the short-term nature of these instruments.
13
Table of Contents
3. Business Combinations
On April 29, 2011, the Company acquired IntraNexus, a provider of Web-based integrated clinical and
hospital information systems. The IntraNexus purchase price totaled $4,204, including contingent
consideration payable over a three year period with a fair value of $800, which was estimated based
on managements forecast of expected revenues, but in no event shall exceed $1,650.
On February 10, 2010, the Company acquired Opus, a provider of clinical information systems to the
small hospital inpatient market. The Opus purchase price totaled $21,113, which includes a fair
value adjustment of $532 to goodwill and the contingent consideration liability that was recorded
during the year ended March 31, 2011. The fair value of the total Opus contingent consideration of
$12,048 was estimated at the time of purchase based on the probability of Opus achieving certain
earnout payments to be paid over a two year period to the selling security holders and former stock
option holders (option holders) of Opus if certain operational and strategic objectives were met.
On March 30, 2011, the Company entered into an amendment to the merger agreement to modify and
accelerate payment of the earnout consideration under the merger agreement, resulting in a total
payment of $12,250, payable in 143,000 shares of Company common stock to the selling security
holders and $856 in cash to the option holders. The Company has no further obligation to pay
earnout consideration related to the Opus acquisition.
The fair value of the Opus earnout settlement was $12,743, which is the fair value of the Opus
contingent consideration recorded in other current liabilities as of March 31, 2011. In reviewing
the final settlement, the Company identified an error in the initial purchase price allocation
related to the fair value of the price collar provisions in the merger agreement. As a result, the
Company recorded an adjustment of $532 to goodwill and contingent consideration liability to
correct the initial purchase price allocation as of February 10, 2010. The Company has concluded
that this correction is not material to any periods affected.
The Company accounted for the IntraNexus, Opus, and NextGen IS acquisitions as purchase business
combinations as defined in FASB ASC Topic 805, Business Combinations, or ASC 805. Under the
acquisition method of accounting, the purchase price was allocated to the tangible and intangible
assets acquired and liabilities assumed based on their estimated fair values as of the acquisition
date. The fair value of the assets acquired and liabilities assumed represent managements
estimate of fair value. The estimated fair value of the acquired tangible and intangible assets
and liabilities assumed were determined using multiple valuation approaches depending on the type
of tangible or intangible asset acquired, including but not limited to the income approach, the
excess earnings method as well as the relief from royalty method approach.
The total purchase price for IntraNexus is summarized as follows:
Cash paid |
$ | 3,279 | ||
Purchase price holdback |
125 | |||
Contingent consideration |
800 | |||
Total purchase price |
$ | 4,204 | ||
The following table summarizes the final allocation of the IntraNexus purchase price:
Fair value of the net tangible assets acquired and liabilities assumed: |
||||
Current assets (including accounts receivable of $464) |
$ | 691 | ||
Accounts payable and accrued liabilities |
(226 | ) | ||
Deferred revenues |
(94 | ) | ||
Total net tangible assets acquired and liabilities assumed |
371 | |||
Fair value of identifiable intangible assets acquired: |
||||
Customer relationships |
1,100 | |||
Software technology |
830 | |||
Goodwill (including assembled workforce of $120) |
1,903 | |||
Total identifiable intangible assets acquired |
3,833 | |||
Total purchase price |
$ | 4,204 | ||
The pro forma effects of the IntraNexus, Opus and NextGen IS acquisitions would not have been
material to the Companys results of operations and is therefore not presented.
14
Table of Contents
4. Goodwill
In accordance with ASC 350-20, the Company does not amortize goodwill as the goodwill has been
determined to have an indefinite useful life.
Goodwill consists of the following:
March 31, | June 30, | |||||||||||
2011 | Acquisitions | 2011 | ||||||||||
NextGen Division |
||||||||||||
NextGen Healthcare Information Systems, Inc. |
$ | 1,840 | $ | | $ | 1,840 | ||||||
Total NextGen Division goodwill |
1,840 | | 1,840 | |||||||||
Inpatient Solutions Division |
||||||||||||
Opus Healthcare Solutions, Inc. |
13,537 | | 13,537 | |||||||||
NextGen Inpatient Solutions, LLC |
1,020 | | 1,020 | |||||||||
IntraNexus, Inc. |
| 1,903 | 1,903 | |||||||||
Total Inpatient Solutions Division goodwill |
14,557 | 1,903 | 16,460 | |||||||||
Practice Solutions Division |
||||||||||||
Practice Management Partners, Inc. |
19,485 | | 19,485 | |||||||||
Healthcare Strategic Initiatives |
10,839 | | 10,839 | |||||||||
Total Practice Solutions Division goodwill |
30,324 | | 30,324 | |||||||||
Total goodwill |
$ | 46,721 | $ | 1,903 | $ | 48,624 | ||||||
5. Intangible Assets
In connection with the IntraNexus acquisition, the Company recorded $1,930 of intangible assets
related to customer relationships and software technology. The Company is amortizing the customer
relationships over 5 years and the software technology over 4 years.
In connection with the Opus acquisition, the Company recorded $13,250 of intangible assets related
to customer relationships and software technology. The Company is amortizing the Opus customer
relationships intangible asset over 4 years and the software technology over 8 years.
In connection with the NextGen IS acquisition, the Company recorded $275 of intangible assets
related to customer relationships and software technology. The Company is amortizing the NextGen
IS customer relationships intangible asset over 4 years and the software technology over 3 years.
In connection with the PMP acquisition, the Company recorded $3,817 of intangible assets related to
customer relationships and trade name. The Company is amortizing the PMP customer relationships
intangible asset over 9 years and trade name over 4 years.
In connection with the HSI acquisition, the Company recorded $5,620 of intangible assets related to
customer relationships and trade name. The Company is amortizing the HSI customer relationships
intangible asset over 6 years and trade name over 4 years.
The Companys intangible assets, other than capitalized software development costs, with
determinable lives are summarized as follows:
June 30, 2011 | ||||||||||||||||
Customer | Software | |||||||||||||||
Relationships | Trade Name | Technology | Total | |||||||||||||
Gross carrying amount |
$ | 11,306 | $ | 637 | $ | 12,949 | $ | 24,892 | ||||||||
Accumulated amortization |
(4,321 | ) | (469 | ) | (2,183 | ) | (6,973 | ) | ||||||||
Net intangible assets |
$ | 6,985 | $ | 168 | $ | 10,766 | $ | 17,919 | ||||||||
March 31, 2011 | ||||||||||||||||
Customer | Software | |||||||||||||||
Relationships | Trade Name | Technology | Total | |||||||||||||
Gross carrying amount |
$ | 10,206 | $ | 637 | $ | 12,119 | $ | 22,962 | ||||||||
Accumulated amortization |
(3,879 | ) | (429 | ) | (1,764 | ) | (6,072 | ) | ||||||||
Net intangible assets |
$ | 6,327 | $ | 208 | $ | 10,355 | $ | 16,890 | ||||||||
15
Table of Contents
Activity related to the intangible assets for the three months ended June 30, 2011 and 2010 is
summarized as follows:
Customer | Software | |||||||||||||||
Relationships | Trade Name | Technology | Total | |||||||||||||
Balance as of April 1, 2011 |
$ | 6,327 | $ | 208 | $ | 10,355 | $ | 16,890 | ||||||||
Acquisition |
1,100 | | 830 | 1,930 | ||||||||||||
Amortization (1) |
(442 | ) | (40 | ) | (419 | ) | (901 | ) | ||||||||
Balance as of June 30, 2011 |
$ | 6,985 | $ | 168 | $ | 10,766 | $ | 17,919 | ||||||||
Customer | Software | |||||||||||||||
Relationships | Trade Name | Technology | Total | |||||||||||||
Balance as of April 1, 2010 |
$ | 7,849 | $ | 368 | $ | 11,928 | $ | 20,145 | ||||||||
Amortization (1) |
(307 | ) | (40 | ) | (418 | ) | (765 | ) | ||||||||
Balance as of June 30, 2010 |
$ | 7,542 | $ | 328 | $ | 11,510 | $ | 19,380 | ||||||||
(1) | Amortization of the customer relationships and trade name intangible assets is included in operating expenses and amortization of the software technology intangible assets is included in cost of revenue for software, hardware and supplies. |
The following table represents the remaining estimated amortization of intangible assets with
determinable lives as of June 30, 2011:
For the year ended March 31,
2012 (remaining nine months) |
$ | 2,810 | ||
2013 |
3,611 | |||
2014 |
3,482 | |||
2015 |
2,441 | |||
2016 and beyond |
5,575 | |||
Total |
$ | 17,919 | ||
6. Capitalized Software Costs
The Companys capitalized software development costs are summarized as follows:
June 30, | March 31, | |||||||
2011 | 2011 | |||||||
Gross carrying amount |
$ | 54,636 | $ | 52,123 | ||||
Accumulated amortization |
(38,898 | ) | (36,973 | ) | ||||
Net capitalized software costs |
$ | 15,738 | $ | 15,150 | ||||
Activity related to net capitalized software costs for the three months ended June 30, 2011 and
2010 is summarized as follows:
2011 | 2010 | |||||||
Balance as of April 1 |
$ | 15,150 | $ | 11,546 | ||||
Capitalized |
2,513 | 2,545 | ||||||
Amortization |
(1,925 | ) | (1,669 | ) | ||||
Balance as of June 30 |
$ | 15,738 | $ | 12,422 | ||||
16
Table of Contents
The following table represents the remaining estimated amortization of capitalized software costs
as of June 30, 2011:
For the year ended March 31,
2012 (remaining nine months) |
$ | 5,701 | ||
2013 |
6,107 | |||
2014 |
3,542 | |||
2015 |
388 | |||
Total |
$ | 15,738 | ||
7. Composition of Certain Financial Statement Captions
Accounts receivable include amounts related to maintenance and services that were billed but not
yet rendered at each period end. Undelivered maintenance and services are included as a component
of the deferred revenue balance on the accompanying consolidated balance sheets.
June 30, | March 31, | |||||||
2011 | 2011 | |||||||
Accounts receivable, excluding undelivered software,
maintenance and services |
$ | 95,913 | $ | 90,487 | ||||
Undelivered software, maintenance and implementation
services billed in advance, included in deferred revenue |
59,790 | 56,002 | ||||||
Accounts receivable, gross |
155,703 | 146,489 | ||||||
Allowance for doubtful accounts |
(6,796 | ) | (6,717 | ) | ||||
Accounts receivable, net |
$ | 148,907 | $ | 139,772 | ||||
Inventories are summarized as follows:
June 30, | March 31, | |||||||
2011 | 2011 | |||||||
Computer systems and components, net of reserve for
obsolescence of $264 |
$ | 2,137 | $ | 1,925 | ||||
Miscellaneous parts and supplies |
8 | 8 | ||||||
Inventories |
$ | 2,145 | $ | 1,933 | ||||
Equipment and improvements are summarized as follows:
June 30, | March 31, | |||||||
2011 | 2011 | |||||||
Computer equipment |
$ | 21,329 | $ | 23,567 | ||||
Furniture and fixtures |
5,596 | 5,861 | ||||||
Leasehold improvements |
3,950 | 4,434 | ||||||
30,875 | 33,862 | |||||||
Accumulated depreciation and amortization |
(17,097 | ) | (21,263 | ) | ||||
Equipment and improvements, net |
$ | 13,778 | $ | 12,599 | ||||
17
Table of Contents
Current and non-current deferred revenue are summarized as follows:
June 30, | March 31, | |||||||
2011 | 2011 | |||||||
Maintenance |
$ | 11,328 | $ | 11,108 | ||||
Implementation services |
56,147 | 52,197 | ||||||
Annual license services |
9,776 | 10,127 | ||||||
Undelivered software and other |
2,776 | 3,263 | ||||||
Deferred revenue |
$ | 80,027 | $ | 76,695 | ||||
Deferred revenue, net of current |
$ | 1,106 | $ | 1,099 | ||||
Accrued compensation and related benefits are summarized as follows:
June 30, | March 31, | |||||||
2011 | 2011 | |||||||
Payroll, bonus and commission |
$ | 3,990 | $ | 5,014 | ||||
Vacation |
5,911 | 5,233 | ||||||
Accrued compensation and related benefits |
$ | 9,901 | $ | 10,247 | ||||
Other current liabilities are summarized as follows:
June 30, | March 31, | |||||||
2011 | 2011 | |||||||
Care services liabilities |
$ | 4,487 | $ | 3,787 | ||||
Accrued EDI expense |
2,344 | 2,801 | ||||||
Sales tax payable |
1,179 | 589 | ||||||
Contingent consideration related to acquisitions |
1,116 | 13,658 | ||||||
Accrued royalties |
1,032 | 1,752 | ||||||
Customer deposits |
908 | 962 | ||||||
Accrued travel |
720 | 1,026 | ||||||
Outside commission payable |
614 | 599 | ||||||
Self insurance reserve |
603 | 475 | ||||||
Deferred rent |
533 | 437 | ||||||
Professional services |
448 | 155 | ||||||
Other accrued expenses |
3,384 | 3,075 | ||||||
Other current liabilities |
$ | 17,368 | $ | 29,316 | ||||
18
Table of Contents
8. Income Tax
The provision for income taxes for the three months ended June 30, 2011 was approximately $9,880 as
compared to approximately $6,989 for the same year ago period. The effective tax rates for the
three months ended June 30, 2011 and 2010 were 34.2% and 36.6%, respectively. The provision for
income taxes for the three months ended June 30, 2011 differs from the combined statutory rates
primarily due to the impact of varying state income tax rates, tax-exempt interest income, and the
qualified production activities deduction. The effective rate for the three months ended June 30,
2011 decreased as compared to the same prior year period primarily due to increased benefits from
the qualified production activities deduction, research and
development credits, which were not included in the provision for the
same prior year period but included in the provision for the current
year period, increased deductions related to incentive stock options
that were exercised in the current quarter and fluctuations in the
state effective tax rate.
Uncertain tax positions
As of June 30, 2011, the Company has provided a liability of $484 for unrecognized tax benefits
related to various federal and state income tax matters. If recognized, $484 would impact the
Companys effective tax rate. The reserve for the three months ended June 30, 2011 decreased from
the same year ago period by $175 due to the expiration of the statute of limitations of prior year
tax positions of acquired companies.
The Companys income tax returns filed for tax years 2007 through 2009 and 2006 through 2009 are
subject to examination by the federal and state taxing authorities, respectively. The Company is
currently under examination by the IRS and is under examination by one state income tax authority
and pending examination by three additional state agencies. The Company does not anticipate that
total unrecognized tax benefits will significantly change due to the settlement of audits or the
expiration of statute of limitations within the next twelve months.
9. Earnings per Share
Pursuant to FASB ASC Topic 260, Earnings Per Share, or ASC 260, the Company provides dual
presentation of basic and diluted earnings per share (EPS).
Basic EPS excludes dilution from common stock equivalents and is computed by dividing income
available to common shareholders by the weighted average number of common shares outstanding for
the period. Diluted EPS reflects the potential dilution from common stock equivalents and is based
on the assumption that the Companys outstanding options are included in the calculation of diluted
earnings per share, except when their effect would be anti-dilutive. Dilution is computed by
applying the treasury stock method. Under this method, options are assumed to be exercised at the
beginning of the period (or at the time of issuance, if later), and as if funds obtained thereby
were used to purchase common stock at the average market price during the period. The following
table reconciles the weighted-average shares outstanding for basic and diluted net income per share
for the periods indicated:
Three Months Ended June 30, | ||||||||
2011 | 2010 | |||||||
Net income |
$ | 18,983 | $ | 12,092 | ||||
Basic net income per share: |
||||||||
Weighted-average shares outstanding Basic |
29,181 | 28,896 | ||||||
Basic net income per common share |
$ | 0.65 | $ | 0.42 | ||||
Net income |
$ | 18,983 | $ | 12,092 | ||||
Diluted net income per share: |
||||||||
Weighted-average shares outstanding Basic |
29,181 | 28,896 | ||||||
Effect of potentially dilutive securities |
219 | 161 | ||||||
Weighted-average shares outstanding Diluted |
29,400 | 29,057 | ||||||
Diluted net income per common share |
$ | 0.65 | $ | 0.42 | ||||
The computation of diluted net income per share does not include 78 and 253 options for the three
months ended June 30, 2011 and 2010, respectively, because their inclusion would have an
anti-dilutive effect on net income per share.
19
Table of Contents
10. Share-Based Awards
Employee Stock Option Plans
In September 1998, the Companys shareholders approved a stock option plan (the 1998 Plan) under
which 4,000,000 shares of common stock were reserved for the issuance of options. The 1998 Plan
provides that employees, directors and consultants of the Company may, at the discretion of the
Board of Directors or a duly designated compensation committee, be granted options to purchase
shares of common stock. The exercise price of each option granted was determined by the Board of
Directors at the date of grant, and options under the 1998 Plan expire no later than ten years from
the grant date. Options granted will generally become exercisable in accordance with the terms of
the agreement pursuant to which they were granted. Certain option grants to directors became
exercisable three months from the date of grant. Upon an acquisition of the Company by merger or
asset sale, each outstanding option may be subject to accelerated vesting under certain
circumstances. The 1998 Plan terminated on December 31, 2007. As of June 30, 2011, there were
173,931 outstanding options related to this Plan.
In October 2005, the Companys shareholders approved a stock option and incentive plan (the 2005
Plan) under which 2,400,000 shares of common stock were reserved for the issuance of awards,
including stock options, incentive stock options and non-qualified stock options, stock
appreciation rights, restricted stock, unrestricted stock, restricted stock units, performance
shares, performance units (including performance options) and other share-based awards. The 2005
Plan provides that employees, directors and consultants of the Company may, at the discretion of
the Board of Directors or a duly designated compensation committee, be granted awards to acquire
shares of common stock. The exercise price of each option award shall be determined by the Board
of Directors at the date of grant in accordance with the terms of the 2005 Plan, and under the 2005
Plan awards expire no later than ten years from the grant date. Options granted will generally
become exercisable in accordance with the terms of the agreement pursuant to which they were
granted. Upon an acquisition of the Company by merger or asset sale, each outstanding option may
be subject to accelerated vesting under certain circumstances. The 2005 Plan terminates on May 25,
2015, unless terminated earlier by the Board of Directors. As of June 30, 2011, there were 667,595
outstanding options and 1,556,924 shares available for future grant related to this Plan.
A summary of stock option transactions during the three months ended June 30, 2011 and 2010 is as
follows:
Weighted- | Weighted- | |||||||||||||||
Average | Average | Aggregate | ||||||||||||||
Exercise | Remaining | Intrinsic | ||||||||||||||
Number of | Price | Contractual | Value | |||||||||||||
Shares | per Share | Life (years) | (in thousands) | |||||||||||||
Outstanding, April 1, 2011 |
698,778 | $ | 44.40 | 3.9 | ||||||||||||
Granted |
229,700 | 86.08 | 7.9 | |||||||||||||
Exercised |
(86,952 | ) | 39.42 | 1.8 | $ | 4,163 | ||||||||||
Forfeited/Canceled |
| | | |||||||||||||
Outstanding, June 30, 2011 |
841,526 | $ | 56.29 | 5.0 | $ | 26,097 | ||||||||||
Vested and expected to vest, June 30, 2011 |
819,212 | $ | 56.14 | 5.0 | $ | 25,530 | ||||||||||
Exercisable, June 30, 2011 |
273,873 | $ | 36.23 | 2.2 | $ | 13,986 | ||||||||||
The Company accounts for share-based compensation in accordance with ASC 718 and utilizes the
Black-Scholes valuation model for estimating the fair value of share-based compensation with the
following assumptions:
Three Months | Three Months | |||||||
Ended | Ended | |||||||
June 30, 2011 | June 30, 2010 | |||||||
Expected life
|
4.3 years | 4.2 years | ||||||
Expected volatility
|
41.2 | % | 44.6% - 44.7 | % | ||||
Expected dividends
|
1.6 | % | 2.1 | % | ||||
Risk-free rate
|
1.8 | % | 2.0% - 2.1 | % |
The weighted average grant date fair value of stock options granted during the three months ended
June 30, 2011 and 2010 was $26.64 and $18.36 per share, respectively.
20
Table of Contents
The Company issues new shares to satisfy option exercises. Based on historical experience of
option cancellations, the Company has estimated an annualized forfeiture rate of 3.3% and 2.4% for
employee options for the three months ended June 30, 2011 and 2010, respectively, and 0.0% for
director options for the three months ended June 30, 2011 and 2010. Forfeiture rates will be
adjusted over the requisite service period when actual forfeitures differ, or are expected to
differ, from the estimate.
During the three months ended June 30, 2011, a total of 229,700 options were granted under the 2005
Plan at an exercise price equal to the market price of the Companys common stock on the date of
grant. A summary of stock options granted under the 2005 Plan during fiscal years 2012 and 2011 is
as follows:
Number of | Vesting | |||||||||||
Option Grant Date | Shares | Exercise Price | Terms (1) | Expires | ||||||||
May 31, 2011 |
229,700 | $ | 86.08 | Five years | May 31, 2019 | |||||||
Fiscal year 2012 option grants |
229,700 | |||||||||||
November 29, 2010 |
10,000 | $ | 64.32 | Five years | November 29, 2018 | |||||||
August 3, 2010 |
5,000 | 55.24 | Five years | August 3, 2018 | ||||||||
June 4, 2010 |
25,000 | 56.29 | Five years | June 4, 2018 | ||||||||
June 2, 2010 |
15,000 | 58.62 | Five years | June 2, 2018 | ||||||||
Fiscal year 2011 option grants |
55,000 | |||||||||||
(1) | Options vest in equal annual installments on each grant anniversary date commencing one year following the date of grant. |
Performance-Based Awards
On May 25, 2011, the Board of Directors approved its fiscal year 2012 equity incentive program for
certain employees to be awarded options to purchase the Companys common stock. The maximum number
of options available under the equity incentive program plan is 300,000, of which 150,000 are
reserved for the Companys named executive officers and 150,000 for non-executive employees of the
Company. Under the program, executives are eligible to receive options based on meeting certain
target increases in earnings per share performance and revenue growth during fiscal year 2012.
Under the program, the non-executive employees are eligible to receive options based on satisfying
certain management established criteria and recommendations of senior management. The options
shall be issued pursuant to one of the Companys shareholder approved option plans, have an
exercise price equal to the closing price of the Companys shares on the date of grant, a term of
eight years and vesting in five equal annual installments commencing one year following the date of
grant.
Compensation expense associated with the performance based awards under the Companys equity
incentive plans are initially based on the number of options expected to vest after assessing the
probability that certain performance criteria will be met. Cumulative adjustments are recorded
quarterly to reflect subsequent changes in the estimated outcome of performance-related conditions.
The Company utilized the Black-Scholes option valuation model and recorded stock compensation
expense related to the performance based awards of approximately $213 and $18 during the three
months ended June 30, 2011 and 2010, respectively, using the assumptions below.
Three Months | Three Months | |||||||
Ended | Ended | |||||||
June 30, 2011 | June 30, 2010 | |||||||
Expected life
|
4.3 years | 4.2 years | ||||||
Expected volatility
|
41.2 | % | 44.4 | % | ||||
Expected dividends
|
1.8 | % | 2.1 | % | ||||
Risk-free rate
|
1.8 | % | 1.8 | % |
21
Table of Contents
Non-vested stock option award activity, including employee stock options and performance-based
awards, during the three months ended June 30, 2011 is summarized as follows:
Weighted- | ||||||||
Average | ||||||||
Non-Vested | Grant-Date | |||||||
Number of | Fair Value | |||||||
Shares | per Share | |||||||
Outstanding, April 1, 2011 |
401,518 | $ | 16.17 | |||||
Granted |
229,700 | 26.64 | ||||||
Vested |
(63,565 | ) | 12.01 | |||||
Forfeited/Canceled |
| | ||||||
Outstanding, June 30, 2011 |
567,653 | $ | 20.87 | |||||
As of June 30, 2011, $9,284 of total unrecognized compensation costs related to stock options is
expected to be recognized over a weighted-average period of 6.4 years. This amount does not
include the cost of new options that may be granted in future periods or any changes in the
Companys forfeiture percentage. The total fair value of options vested during the three months
ended June 30, 2011 and 2010 was $764 and $936, respectively.
Restricted Stock Units
On May 27, 2009, the Board of Directors approved its Outside Director Compensation Plan, whereby
each non-employee Director is to be awarded shares of restricted stock units upon election or
re-election to the Board. The restricted stock units are awarded under the 2005 Plan. Such
restricted stock units vest in two equal, annual installments on the first and second anniversaries
of the grant date and are nontransferable for one year following vesting. Upon each vesting of the
award, one share of common stock shall be issued for each restricted stock unit. The
weighted-average grant date fair value for the restricted stock units was estimated using the
market price of its common stock on the date of grant. The fair value of these restricted stock
units is amortized on a straight-line basis over the vesting period.
As of June 30, 2011, 17,146 restricted stock units have been awarded under this Plan and
approximately $103 and $73 of compensation expense related to these restricted stock units was
recorded during the three months ended June 30, 2011 and 2010, respectively. Restricted stock
units activity for the three months ended June 30, 2011 is summarized as follows:
Weighted- | ||||||||
Average | ||||||||
Grant-Date | ||||||||
Number of | Fair Value | |||||||
Shares | per Share | |||||||
Outstanding, April 1, 2011 |
11,448 | $ | 54.18 | |||||
Granted |
| | ||||||
Vested |
| | ||||||
Outstanding, June 30, 2011 |
11,448 | $ | 54.18 | |||||
As of June 30, 2011, $265 of total unrecognized compensation costs related to restricted stock
units is expected to be recognized over a weighted-average period of 0.8 years. This amount does
not include the cost of new restricted stock units that may be granted in future periods.
11. Concentration of Credit Risk
The Company had cash deposits at U.S. banks and financial institutions which exceeded federally
insured limits at June 30, 2011. The Company is exposed to credit loss for amounts in excess of
insured limits in the event of non-performance by the institutions; however, the Company does not
anticipate non-performance by these institutions.
22
Table of Contents
12. Commitments, Guarantees and Contingencies
Commitments and Guarantees
Software license agreements in both the QSI Dental Division and NextGen Division include a
performance guarantee that the Companys software products will substantially operate as described
in the applicable program documentation for a period of 365 days after delivery. To date, the
Company has not incurred any significant costs associated with its performance guarantee or other
related warranties and does not expect to incur significant warranty costs in the future.
Therefore, no accrual has been made for potential costs associated with these warranties. Certain
arrangements also include performance guarantees related to response time, availability for
operational use, and other performance-related guarantees. Certain arrangements also include
penalties in the form of maintenance credits should the performance of the software fail to meet
the performance guarantees. To date, the Company has not incurred any significant costs associated
with these warranties and does not expect to incur significant warranty costs in the future.
Therefore, no accrual has been made for potential costs associated with these warranties.
The Company has historically offered short-term rights of return in certain sales arrangements. If
the Company is able to estimate returns for these types of arrangements and all other criteria for
revenue recognition have been met, revenue is recognized and these arrangements are recorded in the
consolidated financial statements. If the Company is unable to estimate returns for these types of
arrangements, revenue is not recognized in the consolidated financial statements until the rights
of return expire, provided also, that all other criteria of revenue recognition have been met.
Certain standard sales agreements contain a money back guarantee providing for a performance
guarantee that is already part of the software license agreement as well as training and support.
The money back guarantee also warrants that the software will remain robust and flexible to allow
participation in the federal health incentive programs. The specific elements of the performance
guarantee pertain to aspects of the software, which the Company has already tested and confirmed to
consistently meet using the Companys existing software without any modifications or enhancements.
To date, the Company has not incurred any costs associated with this guarantee and does not expect
to incur significant costs in the future. Therefore, no accrual has been made for potential costs
associated with this guarantee.
The Companys standard sales agreements in the NextGen Division contain an indemnification
provision pursuant to which it shall indemnify, hold harmless, and reimburse the indemnified party
for losses suffered or incurred by the indemnified party in connection with any United States
patent, any copyright or other intellectual property infringement claim by any third-party with
respect to its software. The QSI Dental Division arrangements occasionally utilize this type of
language as well. As the Company has not incurred any significant costs to defend lawsuits or
settle claims related to these indemnification agreements, the Company believes that its estimated
exposure on these agreements is currently minimal. Accordingly, the Company has no liabilities
recorded for these indemnification obligations.
The Company has entered into marketing assistance agreements with existing users of the Companys
products which provide the opportunity for those users to earn commissions if they host specific
site visits upon the Companys request for prospective clients that directly result in a purchase
of the Companys software by the visiting prospects. Amounts earned by existing users under this
program are treated as a selling expense in the period when earned.
Litigation
The Company has experienced certain legal claims by parties asserting that it has infringed certain
intellectual property rights. The Company believes that these claims are without merit and the
Company has defended them vigorously. However, in order to avoid the further legal costs and
diversion of management resources it is reasonably possible that a settlement may be reached which
could result in a liability to the Company. However, at this time it is not possible to estimate
with reasonable certainty what amount, if any, may be incurred as a result of a settlement.
Litigation is inherently uncertain and always difficult to predict. Refer to the discussion of
infringement and litigation risks in the Item 1A. Risk Factors section of the Companys most
recent Annual Report on Form 10-K for the fiscal year ended March 31, 2011.
13. Operating Segment Information
The Company has prepared operating segment information in accordance with ASC 280 to report
components that are evaluated regularly by its chief operating decision maker, or decision making
group, in deciding how to allocate resources and in assessing performance.
During fiscal year 2011, as a result of certain organizational changes, the composition of the
Companys NextGen Division was revised to exclude the Companys inpatient solutions entities (Opus
and NextGen IS), both of which are now aggregated in the Companys Inpatient Solutions Division.
Following the reorganization, the Company now operates four reportable segments (not including
Corporate), comprised of the NextGen Division, the Inpatient Solutions Division, the QSI Dental
Division and the Practice Solutions Division.
Prior period segment results were revised accordingly to reflect the organizational changes. The
results of operations related to the fiscal year 2010 acquisitions of Opus and NextGen IS are now
included in the Inpatient Solutions Division. The results of operations related to the fiscal year
2009 acquisitions of HSI and PMP are included in the Practice Solutions Division.
The QSI Dental Division, co-located with the Companys corporate headquarters in Irvine,
California, currently focuses on developing, marketing and supporting software suites sold to
dental practices.
23
Table of Contents
The NextGen Division, with headquarters in Horsham, Pennsylvania, provides integrated clinical,
financial and connectivity solutions for ambulatory and dental provider organizations and focuses
principally on developing and marketing products and services for medical practices.
The Inpatient Solutions Division, with its primary location in Austin, Texas, provides integrated
clinical, financial and connectivity solutions for rural and community hospitals. The Inpatient
Solutions Division is comprised of IntraNexus, Opus and NextGen IS.
The Practice Solutions Division, with locations in St. Louis, Missouri and Hunt Valley, Maryland,
focuses primarily on providing physician practices with RCM services, primarily billing and
collection services for medical practices. This Division combines a Web-delivered SaaS model and
the NextGenpm software platform to execute its service offerings. The Practice
Solutions Division is comprised of HSI and PMP.
The Divisions operate largely as stand-alone operations, with each Division maintaining its own
distinct product lines, product platforms, development, implementation and support teams and
branding. The Divisions share the resources of the Companys corporate office, which includes a
variety of accounting and other administrative functions. Additionally, there are a small but
growing number of clients who are simultaneously utilizing software or services from more than one
of the Divisions.
In January 2011, QSIH was formed in Bangalore, India to function as the Companys India-based
captive to offshore technology application development and business processing services.
The accounting policies of the Companys operating segments are the same as those described in Note
1, except that the disaggregated financial results of the segments reflect allocation of certain
functional expense categories consistent with the basis and manner in which Company management
internally disaggregates financial information for the purpose of assisting in making internal
operating decisions. Certain corporate overhead costs, such as executive and accounting department
personnel-related expenses, are not allocated to the individual segments by management.
Operating segment data is as follows:
Three Months Ended June 30, | ||||||||
2011 | 2010 | |||||||
Revenue: |
||||||||
QSI Dental Division |
$ | 5,096 | $ | 5,352 | ||||
NextGen Division |
74,624 | 62,671 | ||||||
Inpatient Solutions Division |
7,290 | 3,159 | ||||||
Practice Solutions Division |
13,432 | 11,745 | ||||||
Consolidated revenue |
$ | 100,442 | $ | 82,927 | ||||
Operating income: |
||||||||
QSI Dental Division |
$ | 1,278 | $ | 1,591 | ||||
NextGen Division |
29,325 | 22,554 | ||||||
Inpatient Solutions Division |
3,062 | 235 | ||||||
Practice Solutions Division |
2,041 | 187 | ||||||
Unallocated corporate expense (1) |
(6,887 | ) | (5,540 | ) | ||||
Consolidated operating income |
$ | 28,819 | $ | 19,027 | ||||
(1) | Unallocated corporate expense includes eliminations relating to QSIH revenues and related expenses included in the results of the operating segments. For the three months ended June 30, 2011, eliminations were not significant, and there were no eliminations for the three months ended June 30, 2010. |
Management evaluates performance based upon stand-alone segment operating income. Because the
Company does not evaluate performance based upon return on assets at the operating segment level,
assets are not tracked internally by segment. Therefore, segment asset information is not
presented.
All of the recorded goodwill at June 30, 2011 relates to the Companys NextGen Division, Inpatient
Solutions Division and Practice Solutions Division. The goodwill relating to the acquisitions of
HSI and PMP is recorded in the Practice Solutions Division. The goodwill amounts relating to the
acquisitions of IntraNexus, Opus and NextGen IS are recorded in the Inpatient Solutions Division.
See Note 4.
24
Table of Contents
14. Subsequent Events
On July 26, 2011, the Company acquired 100% of the outstanding common stock of C.Q.I. Solutions,
Inc. (CQI) in exchange for newly issued shares of the
Companys common stock and cash. CQI provides surgery scheduling
software and services for the inpatient market and will be a part of
the Companys Inpatient Solutions Division.
On July 27, 2011, the Board of Directors approved a two-for-one split of the Companys outstanding
shares of common stock and a proportional increase in the number of Company common shares
authorized from 50,000 shares to 100,000 shares. Each shareholder of record at the close of
business on October 6, 2011 will receive one additional share for every outstanding share held on
the record date. The additional shares will be distributed October 26, 2011 and trading will begin
on a split-adjusted basis on October 27, 2011.
On July 27, 2011, the Board of Directors approved a quarterly cash dividend of $0.35 per share on
the Companys outstanding shares of common stock, payable to shareholders of record as of September
16, 2011 with an expected distribution date on or about October 5, 2011.
25
Table of Contents
ITEM 2. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Except for the historical information contained herein, the matters discussed in this managements
discussion and analysis of financial condition and results of operations, or MD&A, including
discussions of our product development plans, business strategies and market factors influencing
our results, may include forward-looking statements that involve certain risks and uncertainties.
Actual results may differ from those anticipated by us as a result of various factors, both
foreseen and unforeseen, including, but not limited to, our ability to continue to develop new
products and increase systems sales in markets characterized by rapid technological evolution,
consolidation, and competition from larger, better-capitalized competitors. Many other economic,
competitive, governmental and technological factors could affect our ability to achieve our goals,
and interested persons are urged to review any risks that may be described in Item 1A. Risk
Factors as set forth herein and other risk factors appearing in our most recent Annual Report on
Form 10-K for the fiscal year ended March 31, 2011 (Annual Report), as supplemented by additional
risk factors, if any, in our interim filings on our Quarterly Report on Form 10-Q, as well as in
our other public disclosures and filings with the Securities and Exchange Commission.
This MD&A is provided as a supplement to the consolidated financial statements and notes thereto
included elsewhere in this Quarterly Report on Form 10-Q in order to enhance your understanding of
our results of operations and financial condition and should be read in conjunction with, and is
qualified in its entirety by, the consolidated financial statements and related notes thereto
included elsewhere in this Quarterly Report on Form 10-Q. Historical results of operations,
percentage margin fluctuations and any trends that may be inferred from the discussion below are
not necessarily indicative of the operating results for any future period.
Our MD&A is organized as follows:
| Management Overview. This section provides a general description of our Company and operating segments, a discussion as to how we derive our revenue, background information on certain trends and developments affecting our Company, a summary of our acquisition transactions and a discussion on managements strategy for driving revenue growth. | ||
| Critical Accounting Policies and Estimates. This section discusses those accounting policies that are considered important to the evaluation and reporting of our financial condition and results of operations, and whose application requires us to exercise subjective or complex judgments in making estimates and assumptions. In addition, all of our significant accounting policies, including our critical accounting policies, are summarized in Note 1, Summary of Significant Accounting Policies, of our notes to consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q. | ||
| Company Overview. This section provides a more detailed description of our Company, operating segments, products and services offered. | ||
| Overview of Results of Operations and Results of Operations by Operating Divisions. These sections provide our analysis and outlook for the significant line items on our consolidated statements of income, as well as other information that we deem meaningful to understand our results of operations on both a consolidated basis and an operating division basis. | ||
| Liquidity and Capital Resources. This section provides an analysis of our liquidity and cash flows. | ||
| New Accounting Pronouncements. This section provides a summary of the most recent authoritative accounting standards and guidance that have either been recently adopted by our Company or may be adopted in the future. |
26
Table of Contents
Management Overview
Quality Systems, Inc. and its wholly-owned subsidiaries operate as four business divisions and are
comprised of: (i) the QSI Dental Division, (ii) the NextGen Division, (iii) the Inpatient
Solutions Division and (iv) the Practice Solutions Division, together with Quality Systems India
Healthcare Private Limited (QSIH). Operationally, Lackland Acquisition II, LLC dba Healthcare
Strategic Initiatives (HSI) and Practice Management Partners, Inc. (PMP) comprise the Practice
Solutions Division while IntraNexus, Inc. (IntraNexus), Opus Healthcare Solutions, LLC (Opus)
and NextGen Inpatient Solutions, LLC (NextGen IS f/k/a Sphere) operate under the Inpatient
Solutions Division. We primarily derive revenue by developing and marketing healthcare information
systems that automate certain aspects of medical and dental practices, networks of practices such
as physician hospital organizations (PHOs) and management service organizations (MSOs),
ambulatory care centers, community health centers and medical and dental schools along with
comprehensive systems implementation, maintenance and support and add on complementary services
such as revenue cycle management (RCM) and electronic data interchange (EDI). Our systems and
services provide our clients with the ability to redesign patient care and other workflow processes
while improving productivity through facilitation of managed access to patient information.
Utilizing our proprietary software in combination with third-party hardware and software solutions,
our products enable the integration of a variety of administrative and clinical information
operations.
The turbulence in the worldwide economy has impacted almost all industries. While healthcare is
not immune to economic cycles, we believe it is more resilient than most segments of the economy.
The impact of the current economic conditions on our existing and prospective clients has been
mixed. We continue to see organizations that are doing fairly well operationally; however, some
organizations with a large dependency on Medicaid populations are being impacted by the challenging
financial condition of the many state governments in whose jurisdictions they conduct business. A
positive factor for U.S. healthcare is the fact that the Obama Administration is pursuing broad
healthcare reform aimed at improving issues surrounding healthcare. The American Recovery and
Reinvestment Act (ARRA), which became law on February 17, 2009, includes more than $20 billion to
help healthcare organizations modernize operations through the acquisition of health care
information technology. The Certification Commission for Health Information Technology
(CCHIT®), a non-profit organization recognized by the Office of the National
Coordinator for Health Information Technology as an approved Authorized Testing and Certification
Body, announced that our EHR solution was certified as a Complete EHR and 2011/2012 compliant
during the quarter ended September 30, 2010, which comes off the heels of the Stage 1 Meaningful
Use definition criteria under the ARRA that was announced in July 2010. With the lifting of the
many Meaningful Use definition uncertainties, which has impacted software revenue, we believe we
are well positioned to aid physicians and hospitals with their EHR decisions as they prepare to
make incentive-based purchases.
Our strategy is, at present, to focus on providing software and services to medical and dental
practices. The key elements of this strategy are to continue development and enhancement of select
software solutions in target markets, to continue to bring further integration between the
Companys ambulatory and inpatient products, to continue investments in our infrastructure
including but not limited to product development, sales, marketing, implementation and support, to
continue efforts to make infrastructure investments within an overall context of maintaining
reasonable expense discipline, to add new clients through maintaining and expanding sales,
marketing and product development activities and to expand our relationship with existing clients
through delivery of add-on and complementary products and services and continuing our gold-standard
commitment of service in support of our client satisfaction programs.
Critical Accounting Policies and Estimates
The discussion and analysis of our consolidated financial statements and results of operations is
based upon our consolidated financial statements, which have been prepared in accordance with
accounting principles generally accepted in the United States of America. The preparation of these
consolidated financial statements requires us to make estimates and judgments that affect the
reported amounts of assets, liabilities, revenue and expenses, and related disclosures of
contingent assets and liabilities. On an on-going basis, we evaluate estimates (including but not
limited to those related to revenue recognition, uncollectible accounts receivable, software
development cost, intangible assets and self-insurance accruals) for reasonableness. We base our
estimates on historical experience and on various other assumptions that management believes to be
reasonable under the circumstances, the results of which form the basis for making judgments about
the carrying values of assets and liabilities that may not be readily apparent from other sources.
Actual results may differ from these estimates under different assumptions or conditions.
We describe our significant accounting policies in Note 2, Summary of Significant Accounting
Policies, of our notes to consolidated financial statements included in our Annual Report. We
discuss our critical accounting policies and estimates in Item 7, Managements Discussion and
Analysis of Financial Condition and Results of Operations, of our Annual Report. There have been
no material changes in our significant accounting policies or critical accounting policies and
estimates since the end of fiscal year 2011.
27
Table of Contents
Company Overview
Quality Systems, Inc., a California corporation formed in 1974, was founded with an early focus on
providing information systems to dental group practices. In the mid-1980s, we capitalized on the
increasing focus on medical cost containment and further expanded our information processing
systems to serve the medical market. In the mid-1990s, we made two acquisitions that accelerated
our penetration of the medical market. These two acquisitions formed the basis for the NextGen
Division. In 2008, we acquired two revenue cycle management companies that formed the basis of our
Practice Solutions Division, which provides revenue cycle management services. In 2009 and 2010,
we made two more acquisitions that formed the basis of our Inpatient Solutions Division. Today, we
serve the physician, inpatient and dental markets through our four business segments: QSI Dental
Division, NextGen Division, Inpatient Solutions Division and Practice Solutions Division.
The following table breaks down our reported segment revenue and segment revenue growth by division
for the three months ended June 30, 2011 and 2010:
Segment Revenue Breakdown | Segment Revenue Growth | |||||||||||||||
Three Months Ended June 30, | Three Months Ended June 30, | |||||||||||||||
2011 | 2010 | 2011 | 2010 | |||||||||||||
QSI Dental Division |
5.1 | % | 6.5 | % | (4.8 | )% | 38.8 | % | ||||||||
NextGen Division |
74.2 | % | 75.5 | % | 19.1 | % | 19.5 | % | ||||||||
Inpatient Solutions Division (1) |
7.3 | % | 3.8 | % | 130.8 | % | N/A | |||||||||
Practice Solutions Division |
13.4 | % | 14.2 | % | 14.4 | % | 13.5 | % | ||||||||
Consolidated |
100.0 | % | 100.0 | % | 21.1 | % | 24.4 | % | ||||||||
(1) | Inpatient Solutions Division consists of three acquisitions: IntraNexus, Opus and NextGen IS, acquired in April 2011, February 2010 and August 2009, respectively. |
QSI Dental Division. The QSI Dental Division, co-located with our corporate headquarters in
Irvine, California, currently focuses on developing, marketing and supporting software suites sold
to dental organizations located throughout the US. In addition, the Division supports a growing
number of organizations utilizing its Software as a Service (SaaS) model-based NextDDS financial
and clinical software and certain number of medical clients that utilize the Divisions UNIX®-based
medical practice management software product.
The QSI Dental Divisions practice management software suite utilizes a UNIX® operating system.
Its Clinical Product Suite (CPS) utilizes the Windows operating system and can be fully
integrated with the practice management software offered from each of our Divisions. CPS
incorporates a wide range of clinical tools including, but not limited to, periodontal charting and
digital imaging of X-ray and inter-oral camera images as part of the electronic patient record.
The Division develops, markets and manages our Dental EDI/connectivity applications including our
QSInet Application Service Provider (ASP). The QSI Dental Division also provides EDI services to
dental Practices. EDI services include electronic submission of claims to insurance providers as
well as automated patient statements.
The QSI Dental Division participates jointly with the NextGen Division in providing software and
services to Federally Qualified Health Centers (FQHCs). FQHCs are community based organizations
funded by the Federal government, which provide medical and dental services to underprivileged and
underserved communities. The Patient Protection and Affordable Care Act, which was signed into law
in March 2010, legislated $11 billion over a multiyear time period for the FQHCs program, creating
unprecedented opportunities for FQHCs growth and the formation of new FQHCs.
In July 2009, we licensed source code that allows us to deliver hosted, Web-based SaaS model
practice management and clinical software solutions to the dental industry. This new software
solution (NextDDS) is being marketed primarily to the multi-location dental group practice
market in which the Division has historically been a dominant player. NextDDS brings the QSI
Dental Division to the forefront of the emergence of Internet-based applications and cloud
computing and represents a significant growth opportunity for the Division to sell both to its
existing client base as well as new clients.
28
Table of Contents
NextGen Division. The NextGen Division, with headquarters in Horsham, Pennsylvania and significant
locations in Atlanta, Georgia, provides integrated clinical, financial and connectivity solutions
for ambulatory and dental provider organizations. The NextGen Divisions major product categories
include the NextGen ambulatory product suite and NextGen Community Connectivity.
The NextGen Ambulatory product suite streamlines patient care with standardized, real-time clinical
and administrative workflows within a physicians practice, and major product categories include
NextGen Electronic Health Records (NextGenehr), NextGen Practice Management
(NextGenpm), NextGen Dashboard, NextGen Mobile and NextGen NextPen. NextGen Community
Connectivity consists of NextGen Health Information Exchange (NextGen HIE, formerly Community
Health Solution), NextGen Patient Portal (NextMD.com), and NextGen Health Quality Measures
(NextGen HQM). The NextGen Division also offers hosting services, NextGuard Data Protection
services, and consulting services, such as strategic governance models and operational
transformation, technical consulting such as data conversions or interface development. The
NextGen Division products utilize Microsoft Windows technology and can operate in a client-server
environment as well as via private intranet, the Internet, or in an ASP environment. The NextGen
Division also provides EDI services, which include electronic submission of claims to insurance
providers as well as automated patient statements.
Practice Solutions Division. The Practice Solutions Division, with locations in St. Louis,
Missouri and Hunt Valley, Maryland, focuses primarily on providing physician practices with RCM
services, primarily billing and collection services for medical practices. This Division combines
a Web-delivered SaaS model and the NextGenpm software platform to execute its service
offerings. Execution of the plan to transition our client base onto the NextGen platform is under
execution. The Practice Solutions Division provides technology solutions and consulting services
to cover the full spectrum of providers revenue cycle needs from patient access through claims
denials.
On May 20, 2008, we acquired St. Louis-based HSI, a full-service healthcare RCM company. Founded
in 1996, HSI provides RCM services to providers including health systems, hospitals and physicians
in private practice with an in-house team consisting of specialists in medical billing, coding and
compliance, payor credentialing and information technology.
On October 28, 2008, as part of our growth strategy for our Practice Solutions Division, we
acquired Maryland-based PMP, a full-service healthcare RCM company. Founded in 2001, PMP provides
physician billing and technology management services to healthcare providers, primarily in the
Mid-Atlantic region. HSI and PMP operate under the umbrella of the Companys Practice Solutions
Division.
Inpatient Solutions Division. The Inpatient Solutions Division, with its primary location in
Austin, Texas, provides integrated clinical, financial and connectivity solutions for rural and
community hospitals. This Division also develops and markets for the small hospital market an
equivalent practice management software product, which performs administrative functions required
for operating a small hospital. The Inpatient Solutions Division products deliver secure, highly
adaptable and easy to use applications to patient centered hospitals and health systems and consist
of NextGen Clinicals and NextGen Financials.
On April 29, 2011, we acquired IntraNexus, a provider of Web-based integrated clinical and hospital
information systems, on February 10, 2010, we acquired Opus, a provider of Web-based clinical
solutions to hospital systems and integrated health networks nationwide and on August 12, 2009, we
acquired NextGen IS, a provider of financial information systems to the small hospital inpatient
market. These acquisitions are part of our strategy to expand into the small hospital market and
to add new clients by taking advantage of cross-selling opportunities between the ambulatory and
inpatient markets. The acquired companies are established developers of software and services for
the inpatient market and operate under the Companys Inpatient Solutions Division.
The Divisions operate largely as stand-alone operations, with each Division maintaining its own
distinct product lines, product platforms, development, implementation and support teams and
branding. The Divisions share the resources of our corporate office, which includes a variety of
accounting and other administrative functions. Additionally, there are a small but growing number
of clients who are simultaneously utilizing software or services from more than one of our
Divisions. The Company is in the process of further integrating the ambulatory and inpatient
products to provide a more robust platform to offer both the inpatient and ambulatory markets.
The QSI Dental Division and NextGen Division develop and market practice management software that
is designed to automate and streamline a number of the administrative functions required for
operating a medical or dental practice. Examples of practice management software functions include
scheduling and billing capabilities, and it is important to note that in both the medical and
dental environments, practice management software systems have already been implemented by the vast
majority of practices. Therefore, we actively compete for the replacement market. In addition,
the QSI Dental Division and NextGen Division develop and market software that automates patient
records in both a practice and hospital setting. Therefore, we are typically competing to replace
paper-based patient record alternatives as opposed to replacing previously purchased systems.
In January 2011, QSIH was formed in Bangalore, India to function as the Companys India-based
captive to offshore technology application development and business processing services.
We continue to pursue product and service enhancement initiatives within each Division. The
majority of such expenditures are currently targeted to the NextGen Division product line and
client base.
29
Table of Contents
Overview of Our Results
§ | Consolidated revenue increased 21.1% and income from operations grew by 51.5% in the three months ended June 30, 2011 as compared to the same prior year period. Revenue was positively impacted by growth in recurring revenue, including maintenance, EDI and RCM revenue, which grew 23.4%, 23.8% and 10.3%, respectively and accounted for 55.2% of total consolidated revenue for the three months ended June 30, 2011. In the same period a year ago, recurring revenue represented 55.6% of total consolidated revenue. Revenue was also positively impacted by growth in sales of systems, which increased 18.3% in the three months ended June 30, 2011 as compared to the same prior year period. |
§ | The increase in income from operations was partially offset by: (a) higher selling, general and administrative expenses, which was primarily a result of increased headcount expenses and selling-related expenses at the NextGen Division, (b) increased research and development costs and (c) higher corporate-related expenses. |
§ | We have benefited and hope to continue to benefit from the increased demands on healthcare providers for greater efficiency and lower costs, financial incentives from the ARRA to physicians who adopt electronic health records, as well as increased adoption rates for electronic health records and other technology in the healthcare arena. |
§ | While we expect to benefit from the increasing demands for greater efficiency as well as government support for increased adoption of electronic health records, the current economic environment, combined with unpredictability of the federal governments plans to promote increased adoption of electronic medical records, makes the near term achievement of such benefits and, ultimately, their impact on system sales, uncertain. |
NextGen Division
§ | NextGen Division revenue increased 19.1% in the three months ended June 30, 2011 and divisional operating income (excluding unallocated corporate expenses) increased 30.0% as compared to the same prior year period. |
§ | Recurring revenue, which consists of maintenance and EDI revenue, increased 23.8% to $37.4 million and accounted for 50.1% of total NextGen Division revenue for the three months ended June 30, 2011. In the same period a year ago, recurring revenue of $30.2 million represented 48.2% of total NextGen Division revenue. |
§ | During the three months ended June 30, 2011, we added staffing resources and increased our investment in research and development in anticipation of growth from the ARRA. Our goals include taking maximum advantage of benefits related to the ARRA and continuing to further enhance our existing products, including continued efforts to maintain our status as a qualified vendor under the ARRA, integrating our inpatient and ambulatory software products, developing new products for targeted markets, continuing to add new clients, selling additional software and services to existing clients, expanding penetration of connectivity and other services to new and existing clients, and capitalizing on growth and cross selling opportunities within the Practice Solutions Division and the Inpatient Solutions Division. |
§ | The NextGen Divisions growth is attributed to a strong brand name and reputation within a growing marketplace for electronic health records and investments in sales and marketing activities, including new marketing campaigns, trade show attendance and other expanded advertising and marketing expenditures. We have also benefited from winning numerous industry awards for the NextGen Divisions flagship NextGenehr and NextGenpm software products and more recently in 2010 for its NextGen HIE product. Further, the increasing acceptance of electronic records technology in the healthcare industry continues to provide growth opportunities. |
QSI Dental Division
§ | QSI Dental Division revenue decreased 4.8% in the three months ended June 30, 2011 and divisional operating income (excluding unallocated corporate expenses) decreased 19.7% as compared to the same prior year period. |
§ | The QSI Dental Division is well-positioned to sell to the FQHCs market and intends to continue leveraging the NextGen Divisions sales force to sell its dental electronic medical records software to practices that provide both medical and dental services, such as FQHCs, which are receiving grants as part of the ARRA. |
§ | Our goal for the QSI Dental Division is to maximize profit performance given the constraints represented by a relatively weak purchasing environment in the dental group practice market while taking advantage of opportunities with the new NextDDS product. |
Practice Solutions Division
§ | Practice Solutions Division revenue increased 14.4% in the three months ended June 30, 2011. Divisional operating income (excluding unallocated corporate expenses) increased to $2.0 million in the three months ended June 30, 2011 as compared to $0.2 for the same prior year period. |
§ | The Practice Solutions Division benefited from organic growth achieved through cross selling RCM services to existing NextGen Division clients and well as new clients added during the three months ended June 30, 2011. |
§ | Operating income as a percentage of revenue increased to approximately 15.2% of revenue in the three months ended June 30, 2011 versus 1.6% of revenue in the same prior year period primarily as a result of higher RCM revenue. The same prior year period also included higher expenses related to certain non-recurring integration related expenses related to integrating the two entities that make up the Division, transitioning and training of staff on the NextGen platform, initial set up and other costs related to achieving higher production volume from a new business. |
30
Table of Contents
Inpatient Solutions Division
§ | Inpatient Solutions Division revenue increased 130.8% in the three months ended June 30, 2011. Divisional operating income (excluding unallocated corporate expenses) increased to $3.1 million for the three months ended June 30, 2011 as compared to $0.2 for the same prior year period. This Division consists of three acquisitions, IntraNexus, Opus and NextGen IS, acquired in April 2011, February 2010 and August 2009, respectively. |
§ | The Inpatient Solutions Division has benefited from being able to offer both financial and CCHIT® certified clinical software, which has been packaged together. The Division has also benefited from cross-sell opportunities with existing NextGen Division customers, including hospitals that are owned or affiliated with physician offices. |
§ | Operating income as a percentage of revenue increased to approximately 42.0% of revenue in the three months ended June 30, 2011 versus 7.4% of revenue in the same prior year period primarily as a result of a $4.1 million increase in divisional revenue, including system sales, implementation and training services, and maintenance. |
The following table sets forth, for the periods indicated, the percentage of net revenue
represented by each item in our consolidated statements of income (certain percentages below may
not sum due to rounding):
Three Months Ended June 30, | ||||||||
(Unaudited) | 2011 | 2010 | ||||||
Revenues: |
||||||||
Software, hardware and supplies |
28.8 | % | 29.9 | % | ||||
Implementation and training services |
5.4 | 5.2 | ||||||
System sales |
34.2 | 35.0 | ||||||
Maintenance |
31.4 | 30.8 | ||||||
Electronic data interchange services |
12.0 | 11.8 | ||||||
Revenue cycle management and related services |
11.8 | 13.0 | ||||||
Other services |
10.5 | 9.4 | ||||||
Maintenance, EDI, RCM and other services |
65.8 | 65.0 | ||||||
Total revenues |
100.0 | 100.0 | ||||||
Cost of revenue: |
||||||||
Software, hardware and supplies |
4.6 | 7.5 | ||||||
Implementation and training services |
4.1 | 3.6 | ||||||
Total cost of system sales |
8.7 | 11.1 | ||||||
Maintenance |
3.8 | 4.2 | ||||||
Electronic data interchange services |
7.9 | 8.1 | ||||||
Revenue cycle management and related services |
8.8 | 9.8 | ||||||
Other services |
5.6 | 5.2 | ||||||
Total cost of maintenance, EDI, RCM and other services |
26.1 | 27.3 | ||||||
Total cost of revenue |
34.8 | 38.4 | ||||||
Gross profit |
65.2 | 61.6 | ||||||
Operating expenses: |
||||||||
Selling, general and administrative |
29.3 | 31.6 | ||||||
Research and development costs |
6.8 | 6.6 | ||||||
Amortization of acquired intangible assets |
0.5 | 0.4 | ||||||
Total operating expenses |
36.5 | 38.6 | ||||||
Income from operations |
28.7 | 22.9 | ||||||
Interest income |
0.1 | 0.1 | ||||||
Other expense, net |
0.0 | 0.0 | ||||||
Income before provision for income taxes |
28.7 | 23.0 | ||||||
Provision for income taxes |
9.8 | 8.4 | ||||||
Net income |
18.9 | % | 14.6 | % | ||||
31
Table of Contents
Comparison of the Three Months Ended June 30, 2011 and June 30, 2010
During fiscal year 2011, as a result of certain organizational changes, the composition of the
Companys NextGen Division was revised to exclude the Companys inpatient solutions entities (Opus
and NextGen IS), both of which are now aggregated in the Companys Inpatient Solutions Division.
Following the reorganization, the Company now operates four reportable segments (not including
Corporate), comprised of the NextGen Division, the Inpatient Solutions Division, the QSI Dental
Division and the Practice Solutions Division.
Prior period segment results were revised accordingly to reflect the organizational changes. The
results of operations related to the fiscal year 2010 acquisitions of Opus and NextGen IS are now
included in the Inpatient Solutions Division. The results of operations related to the fiscal year
2009 acquisitions of HSI and PMP are included in the Practice Solutions Division.
Net Income. The Companys net income for the three months ended June 30, 2011 was $19.0 million,
or $0.65 per share on both a basic and fully diluted basis. In comparison, we earned $12.1
million, or $0.42 per share on a basic and fully diluted basis for the three months ended June 30,
2010. The increase in net income for the three months ended June 30, 2011 was primarily attributed
to the following:
| a 21.1% increase in consolidated revenue, including an increase in revenues of $12.0 million from our NextGen Division, $4.1 million from our Inpatient Solutions Division and $1.7 million from our Practice Solutions Division; | ||
| a 19.1% increase in NextGen Division revenue, which accounted for 74.3% of consolidated revenue; | ||
| an increase of recurring revenue, including RCM, maintenance and EDI revenue, which accounted for 55.2% of total consolidated revenue; | ||
| offset by an increase in selling, general and administrative expenses and research and development costs. |
Revenue. Revenue for the three months ended June 30, 2011 increased 21.1% to $100.4 million from
$82.9 million for the three months ended June 30, 2010. NextGen Division revenue increased 19.1%
to $74.6 million from $62.7 million in the three months ended June 30, 2010, QSI Dental Division
revenue decreased 4.8% to $5.1 million from $5.4 million, Practice Solutions Division revenue
increased 14.4% to $13.4 million from $11.7 million, and Inpatient Solutions Division revenue
increased 130.8% during that same period to $7.3 million from $3.2 million.
System Sales. Revenue earned from Company-wide sales of systems for the three months ended June
30, 2011 increased 18.3% to $34.4 million from $29.1 million in the same prior year period.
Our increase in revenue from sales of systems was principally the result of a 9.2% increase in
category revenue at our NextGen Division and a 244.9% increase at our Inpatient Solutions Division.
NextGen Division sales in this category grew $2.4 million to $28.1 million during the three months
ended June 30, 2011 from $25.8 million during the same prior year period while the Inpatient
Solutions Division delivered a $2.7 million increase in category revenue to $3.8 million in the
three months ended June 30, 2011 as compared to $1.1 million in the same prior year period. The
increases were driven by higher sales of software to both new and existing clients at the NextGen
Division and higher software and implementation revenue at the Inpatient Solutions Division.
The following table breaks down our reported system sales into software, hardware, third-party
software, supplies and implementation and training services components on a consolidated and
divisional basis for the three months ended June 30, 2011 and 2010 (in thousands):
Hardware, Third | Implementation | |||||||||||||||
Party Software | and Training | Total System | ||||||||||||||
Software | and Supplies | Services | Sales | |||||||||||||
Three Months Ended June 30, 2011 |
||||||||||||||||
QSI Dental Division |
$ | 896 | $ | 395 | $ | 420 | $ | 1,711 | ||||||||
NextGen Division |
23,172 | 1,317 | 3,653 | 28,142 | ||||||||||||
Inpatient Solutions Division |
2,310 | 153 | 1,325 | 3,788 | ||||||||||||
Practice Solutions Division |
668 | | 74 | 742 | ||||||||||||
Consolidated |
$ | 27,046 | $ | 1,865 | $ | 5,472 | $ | 34,383 | ||||||||
Three Months Ended June 30, 2010 |
||||||||||||||||
QSI Dental Division |
$ | 874 | $ | 883 | $ | 236 | $ | 1,993 | ||||||||
NextGen Division |
18,715 | 3,212 | 3,841 | 25,768 | ||||||||||||
Inpatient Solutions Division |
895 | 24 | 179 | 1,098 | ||||||||||||
Practice Solutions Division |
153 | | 52 | 205 | ||||||||||||
Consolidated |
$ | 20,637 | $ | 4,119 | $ | 4,308 | $ | 29,064 | ||||||||
32
Table of Contents
NextGen Division software license revenue increased 23.8% in the three months ended June 30, 2011
versus the same period last year. The Divisions software revenue accounted for 82.3% of
divisional system sales revenue during the three months ended June 30, 2011 compared to 72.6%
during the same period a year ago. Software license revenue continues to be an area of primary
emphasis for the NextGen Division.
During the three months ended June 30, 2011, 4.7% of the NextGen Divisions system sales revenue
was represented by hardware and third-party software compared to 12.5% during same period a year
ago. The number of clients who purchase hardware and third-party software and the dollar amount of
hardware and third-party software revenue fluctuates each quarter depending on the needs of
clients. The inclusion of hardware and third-party software in the Divisions sales arrangements
is typically at the request of our clients.
Implementation and training revenue related to system sales at the NextGen Division decreased 4.9%
in the three months ended June 30, 2011 compared to the same prior year period. Implementation and
training revenue related to system sales at the Inpatient Solutions Division increased $1.1 million,
or 640.2%, in the three months ended June 30, 2011 as compared to the same prior year
period. The amount of implementation and training services revenue is dependent on several
factors, including timing of client implementations, the availability of qualified staff and the
mix of services being rendered. The number of implementation and training staff increased during
the three months ended June 30, 2011 versus the same prior year period in order to accommodate the
increased amount of implementation services sold in conjunction with increased software sales. In
order to achieve growth in this area, additional staffing increases and additional training
facilities are anticipated, though actual future increases in revenue and staff will depend upon
the availability of qualified staff, business mix and conditions and our ability to retain current
staff members.
For the QSI Dental Division, total system sales decreased $0.3 million, or 14.2%, to $1.7 million
in the three months ended June 30, 2011 as compared to $2.0 million in the same prior year period.
Systems sales in the same prior year period included a larger amount of hardware compared to the
current year period.
For the Practice Solutions Division, total system sales increased $0.5 million, or 262.4%, to $0.7
million in the three months ended June 30, 2011 as compared to the same prior year period. Systems
sales revenue within the Practice Solutions Division is composed of sales to existing RCM clients
only and can fluctuate given the size of the current client base of the Practice Solutions
Division.
Maintenance, EDI, RCM and Other Services. For the three months ended June 30, 2011, Company-wide
revenue from maintenance, EDI, RCM and other services grew 22.6% to $66.1 million from $53.9
million in the same prior year period. The increase is primarily due to an increase in
maintenance, EDI and other services revenue from the NextGen Division and RCM revenue from the
Practice Solutions Division.
Total NextGen Division maintenance revenue for the three months ended June 30, 2011 grew 22.4% to
$26.5 million from $21.6 million for the same prior year period while NextGen Division EDI revenue
grew 27.3% to $10.9 million compared to $8.5 million in the same prior year period. Other services
revenue for the NextGen Division, which consists primarily of third-party annual software license
renewals, follow-on training hours, consulting services and hosting services, increased 35.5% to
$9.1 million in the three months ended June 30, 2011 from $6.7 million in the same prior year
period. Other services revenue benefited from a strong increase in consulting revenue and
follow-on training services revenue to existing NextGen Division customers.
QSI Dental Division maintenance, EDI and other services revenue for the three months ended June 30,
2011 and 2010 was $3.4 million. For the three months ended June 30, 2011, RCM revenue grew $1.1
million, or 10.3%, to $11.9 million compared to $10.8 million in the same prior year period
primarily as a result of increases in RCM revenue to new and existing clients. For the Inpatient
Solutions Division, maintenance and other services revenue for the three months ended June 30, 2011
increased 70.0% as compared to the same prior year period primarily because divisional maintenance
revenue increased $1.1 million to $3.1 million from $2.0 million in the same prior year period.
33
Table of Contents
The following table details maintenance, EDI, RCM and other services revenue by category on a
consolidated and divisional basis for the three months ended June 30, 2011 and 2010 (in thousands):
Maintenance | EDI | RCM | Other | Total | ||||||||||||||||
Three Months Ended June 30,
2011 |
||||||||||||||||||||
QSI Dental Division |
$ | 1,849 | $ | 1,221 | $ | | $ | 315 | $ | 3,385 | ||||||||||
NextGen Division |
26,504 | 10,871 | | 9,107 | 46,482 | |||||||||||||||
Inpatient Solutions Division |
3,109 | | | 393 | 3,502 | |||||||||||||||
Practice Solutions Division |
40 | | 11,881 | 769 | 12,690 | |||||||||||||||
Consolidated |
$ | 31,502 | $ | 12,092 | $ | 11,881 | $ | 10,584 | $ | 66,059 | ||||||||||
Three Months Ended June 30,
2010 |
||||||||||||||||||||
QSI Dental Division |
$ | 1,837 | $ | 1,224 | $ | | $ | 298 | $ | 3,359 | ||||||||||
NextGen Division |
21,645 | 8,540 | | 6,719 | 36,904 | |||||||||||||||
Inpatient Solutions Division |
2,016 | | | 44 | 2,060 | |||||||||||||||
Practice Solutions Division |
38 | | 10,772 | 730 | 11,540 | |||||||||||||||
Consolidated |
$ | 25,536 | $ | 9,764 | $ | 10,772 | $ | 7,791 | $ | 53,863 | ||||||||||
Maintenance revenue for the NextGen Division increased by $4.9 million for the three months ended
June 30, 2011 as compared to the same prior year period. The growth in maintenance revenue is a
result of a $4.0 million increase related to net additional licenses from new clients and existing
clients and approximately $0.9 million related to a price increase that became effective during the
quarter ended September 30, 2010.
The NextGen Divisions EDI revenue growth has come from new clients and from further penetration of
the Divisions existing client base while the growth in RCM revenue has come from new clients that
have been acquired from cross selling opportunities with the NextGen Division client base. We
intend to continue to promote maintenance, EDI and RCM services to both new and existing clients.
Growth in other services revenue is primarily due to increases in third-party annual software
licenses, follow on training services, consulting services and hosting services revenue.
Cost of Revenue. Cost of revenue for the three months ended June 30, 2011 increased 9.6% to $34.9
million from $31.9 million in the same prior year period and the cost of revenue as a percentage of
revenue decreased to 34.8% from 38.4% primarily due to a lower amount of hardware included in
systems sales as compared to the same prior year period as well as higher margins achieved from EDI
revenue in the current year period.
34
Table of Contents
The following table details revenue and cost of revenue on a consolidated and divisional basis
for the three months ended June 30, 2011 and 2010 (in thousands):
Three Months Ended June 30, | ||||||||||||||||
2011 | % | 2010 | % | |||||||||||||
QSI Dental Division |
||||||||||||||||
Revenue |
$ | 5,096 | 100.0 | % | $ | 5,352 | 100.0 | % | ||||||||
Cost of revenue |
2,256 | 44.3 | % | 2,392 | 44.7 | % | ||||||||||
Gross profit |
$ | 2,840 | 55.7 | % | $ | 2,960 | 55.3 | % | ||||||||
NextGen Division |
||||||||||||||||
Revenue |
$ | 74,624 | 100.0 | % | $ | 62,671 | 100.0 | % | ||||||||
Cost of revenue |
21,466 | 28.8 | % | 20,212 | 32.3 | % | ||||||||||
Gross profit |
$ | 53,158 | 71.2 | % | $ | 42,459 | 67.7 | % | ||||||||
Inpatient Solutions Division |
||||||||||||||||
Revenue |
$ | 7,290 | 100.0 | % | $ | 3,159 | 100.0 | % | ||||||||
Cost of revenue |
1,648 | 22.6 | % | 852 | 27.0 | % | ||||||||||
Gross profit |
$ | 5,642 | 77.4 | % | $ | 2,307 | 73.0 | % | ||||||||
Practice Solutions Division |
||||||||||||||||
Revenue |
$ | 13,432 | 100.0 | % | $ | 11,745 | 100.0 | % | ||||||||
Cost of revenue |
9,138 | 68.0 | % | 8,403 | 71.5 | % | ||||||||||
Gross profit |
$ | 4,294 | 32.0 | % | $ | 3,342 | 28.5 | % | ||||||||
Unallocated cost of revenue (1) |
$ | 420 | N/A | $ | | N/A | ||||||||||
Consolidated |
||||||||||||||||
Revenue |
$ | 100,442 | 100.0 | % | $ | 82,927 | 100.0 | % | ||||||||
Cost of revenue |
34,928 | 34.8 | % | 31,859 | 38.4 | % | ||||||||||
Gross profit |
$ | 65,514 | 65.2 | % | $ | 51,068 | 61.6 | % | ||||||||
(1) | Relates to the amortization of software technology intangible assets acquired from the purchases of IntraNexus, Opus and NextGen IS. |
Gross profit margins at the QSI Dental Division for the three months ended June 30, 2011
increased slightly to 55.7% from 55.3% for the same prior year period. Gross profit margins at the
NextGen Division for three months ended June 30, 2011 increased to 71.2% compared to 67.7% for the
same prior year period due to strong software sales and an increase in maintenance revenue, which
yields higher margins than other services, along with improvements in EDI margins. Gross margin in
the Inpatient Solutions Division increased to 77.4% for the three months ended June 30, 2011 as
compared to 73.0% for the same prior year period due to growth in higher margin software and
maintenance revenue. Gross margin in the Practice Solutions Division increased to 32.0% for the
three months ended June 30, 2011 as compared to 28.5% for the same prior year period due to growth
in higher margin software revenue.
35
Table of Contents
The following table details the individual components of cost of revenue and gross profit as a
percentage of total revenue on a consolidated and divisional basis for the three months ended June
30, 2011 and 2010:
Hardware, | Payroll and | |||||||||||||||||||||||
Third Party | Related | Total Cost | ||||||||||||||||||||||
Software | Benefits | EDI | Other | of Revenue | Gross Profit | |||||||||||||||||||
Three Months Ended June 30, 2011 |
||||||||||||||||||||||||
QSI Dental Division |
7.6 | % | 19.5 | % | 9.3 | % | 7.9 | % | 44.3 | % | 55.7 | % | ||||||||||||
NextGen Division |
1.5 | % | 12.1 | % | 8.5 | % | 6.7 | % | 28.8 | % | 71.2 | % | ||||||||||||
Inpatient Solutions Division |
2.9 | % | 14.8 | % | 0.0 | % | 4.9 | % | 22.6 | % | 77.4 | % | ||||||||||||
Practice Solutions Division |
0.0 | % | 43.3 | % | 1.8 | % | 22.9 | % | 68.0 | % | 32.0 | % | ||||||||||||
Consolidated |
1.7 | % | 16.8 | % | 7.0 | % | 9.3 | % | 34.8 | % | 65.2 | % | ||||||||||||
Three Months Ended June 30, 2010 |
||||||||||||||||||||||||
QSI Dental Division |
11.6 | % | 14.4 | % | 12.5 | % | 6.2 | % | 44.7 | % | 55.3 | % | ||||||||||||
NextGen Division |
4.3 | % | 12.6 | % | 8.8 | % | 6.6 | % | 32.3 | % | 67.7 | % | ||||||||||||
Inpatient Solutions Division |
1.1 | % | 24.6 | % | 0.0 | % | 1.3 | % | 27.0 | % | 73.0 | % | ||||||||||||
Practice Solutions Division |
0.0 | % | 44.4 | % | 0.0 | % | 27.1 | % | 71.5 | % | 28.5 | % | ||||||||||||
Consolidated |
4.2 | % | 18.1 | % | 7.8 | % | 8.3 | % | 38.4 | % | 61.6 | % | ||||||||||||
During the three months ended June 30, 2011, hardware and third-party software constituted a
higher portion of cost of revenue compared to the same prior year period in the NextGen Division.
The number of clients who purchase hardware and third-party software and the dollar amount of
hardware and third-party software purchased fluctuates each quarter depending on the needs of our
clients.
Our payroll and benefits expense associated with delivering our products and services decreased to
16.8% of consolidated revenue in the three months ended June 30, 2011 compared to 18.1% during the
same period last year. The absolute level of consolidated payroll and benefit expenses grew from
$15.1 million in the three months ended June 30, 2010 to $16.9 million in the three months ended
June 30, 2011, an increase of 12.2%, or approximately $1.8 million. Of the $1.8 million increase,
approximately $0.6 million of the increase is related to the Practice Solutions Division as RCM is
a service business, which inherently has higher percentage of payroll costs as a percentage of
revenue. Increases of $0.7 million in the NextGen Division, $0.3 million for the Inpatient
Solutions Division and $0.2 million in the QSI Dental Division for the three months ended June 30,
2011 are primarily due to headcount additions and increased payroll and benefits expense associated
with delivering products and services. The amount of share-based compensation expense included in
cost of revenue was not significant for three months ended June 30, 2011 and 2010.
Other expense, which primarily consists of third-party annual license, hosting costs and
outsourcing costs, increased to 9.3% of total revenue during the three months ended June 30, 2011
as compared to 8.3% for the same period a year ago. Contributing to this increase was higher costs
relating to hosting and annual licenses revenues that are included in other services in the NextGen
Division and Inpatient Solutions Division.
As a result of the foregoing events and activities, the gross profit percentage for the Company
increased to 65.2% for the three months ended June 30, 2011 versus 61.6% for the same prior year
period.
We anticipate continued additions to headcount in all of our Divisions in areas related to
delivering products and services in future periods, but due to the uncertainties in the timing of
our sales arrangements, our sales mix, the acquisition and training of qualified personnel and
other issues, we cannot accurately predict if related headcount expense as a percentage of revenue
will increase or decrease in the future.
36
Table of Contents
Selling, General and Administrative Expenses. Selling, general and administrative expenses for the
three months ended June 30, 2011 increased 12.0% to $29.4 million as compared to $26.2 million for
the same prior year period. The increase in these expenses resulted primarily from:
| $2.3 million increase in salaries and related benefit expenses primarily as a result of headcount additions; | ||
| $1.6 million increase in sales commissions primarily related to the NextGen Division; partially offset by | ||
| $0.7 million net decrease in other selling and administrative expenses. |
Share-based compensation expense was approximately $0.9 million and $1.0 million for the three
months ended June 30, 2011and 2010, respectively, and is included in the aforementioned amounts.
Selling, general and administrative expenses as a percentage of revenue decreased from 31.6% in the
three months ended June 30, 2010 to 29.3% in the three months ended June 30, 2011.
We do not anticipate significant increases in expenditures for trade shows, advertising and the
employment of additional sales and administrative staff at the NextGen Division until additional
revenue growth is achieved. We anticipate future increases in corporate expenditures being made in
a wide range of areas including professional services and investment in a companywide enterprise
resource planning (ERP) system. While we expect selling, general and administrative expenses to
increase on an absolute basis, we cannot accurately predict the impact these additional
expenditures will have on selling, general and administrative expenses as a percentage of revenue.
Research and Development Costs. Research and development costs for the three months ended June 30,
2011 and 2010 were $6.8 million and $5.5 million, respectively. The increases in research and
development expenses were due in part to increased investment in the NextGen Division product line.
Additions to capitalized software costs offset increases in research and development costs. For
the three months ended June 30, 2011 and 2010, our additions to capitalized software were at $2.5
million as we continue to enhance our software to meet the Meaningful Use definitions under the
ARRA as well as further integrate both ambulatory and inpatient products. Research and development
costs as a percentage of revenue increased to 6.8% in the three months ended June 30, 2011 from
6.6% for the same prior year period. Research and development expenses are expected to continue at
or above current dollar levels as the Company is developing a new integrated inpatient and
outpatient, web-based software platform. Share-based compensation expense included in research and
development costs was not significant for three months ended June 30, 2011 and 2010.
Amortization of Acquired Intangible Assets. Amortization in operating expense related to acquired
intangible assets for the three months ended June 30, 2011 and 2010 were $0.5 million and $0.3
million, respectively.
Interest and Other Income. Total interest and other income for the three months ended June 30,
2011 and 2010 were $0.1 million. Interest and other income consist primarily of dividends and
interest earned on our investments.
Our investment policy is determined by our Board of Directors. We currently maintain our cash in
very liquid short term assets including tax exempt and taxable money market funds and short-term
U.S. Treasury securities with maturities of 90 days or less at the time of purchase. Our Board of
Directors continues to review alternate uses for our cash including, but not limited to, payment of
a special dividend, initiation of a stock buyback program, an expansion of our investment policy to
include investments with longer maturities of greater than 90 days, and other items. Additionally,
it is possible that we will utilize some or all of our cash to fund acquisitions or other similar
business activities. Any or all of these programs could significantly impact our investment income
in future periods.
Provision for Income Taxes. The provision for income taxes for the three months ended June 30,
2011 and 2010 were $9.9 million and $7.0 million, respectively. The effective tax rates were 34.2%
and 36.6% for the three months ended June 30, 2011 and 2010, respectively. The effective rate for
the three months ended June 30, 2011 decreased as compared to the same prior year period primarily
due to increased benefits from the qualified production activities deduction, research and
development credits, which were not included in the provision for the same prior year period but
included in the provision for the current year period, increased deductions related to incentive
stock options that were exercised in the current quarter and fluctuations in the state effective
tax rate.
37
Table of Contents
Liquidity and Capital Resources
The following table presents selected financial statistics and information for the three months
ended June 30, 2011 and 2010 (dollar amounts in thousands):
Three Months Ended June 30, | ||||||||
2011 | 2010 | |||||||
Cash and cash equivalents |
$ | 124,054 | $ | 93,208 | ||||
Net increase in cash and cash equivalents |
$ | 7,437 | $ | 8,597 | ||||
Net income |
$ | 18,983 | $ | 12,092 | ||||
Net cash provided by operating activities |
$ | 21,533 | $ | 19,366 | ||||
Number of days of sales outstanding |
135 | 123 |
Cash Flows from Operating Activities
Cash provided by operations has historically been our primary source of cash and has primarily been
driven by our net income plus adjustments to add back non-cash expenses, including depreciation,
amortization of intangibles and capitalized software costs, provisions for bad debts and inventory
obsolescence, share-based compensation and deferred taxes.
The following table summarizes our consolidated statements of cash flows for the three months ended
June 30, 2011 and 2010 (in thousands):
Three Months Ended June 30, | ||||||||
2011 | 2010 | |||||||
Net income |
$ | 18,983 | $ | 12,092 | ||||
Non-cash expenses |
6,006 | 5,049 | ||||||
Change in deferred revenue |
3,245 | (214 | ) | |||||
Change in accounts receivable |
(9,651 | ) | (4,924 | ) | ||||
Change in other assets and liabilities |
2,950 | 7,363 | ||||||
Net cash provided by operating activities |
$ | 21,533 | $ | 19,366 | ||||
Net Income. As referenced in the above table, net income makes up the majority of our cash
generated from operations for the three months ended June 30, 2011 and 2010. The NextGen
Divisions contribution to net income has increased each year due to that Divisions operating
income increasing more quickly than the Company as a whole.
Non-Cash Expenses. Non-cash expenses include depreciation, amortization of intangibles and
capitalized software costs, provisions for bad debts, share-based compensation and deferred taxes.
Total non-cash expenses were $6.0 million and $5.0 million three months ended June 30, 2011 and
2010, respectively.
The $1.0 million increase in non-cash expenses for the three months ended June 30, 2011 as compared
to the same prior year period is primarily related to increases of approximately $0.3 million in
depreciation, $0.3 million of amortization of capitalized software costs, $0.1 million of
amortization of other intangibles, and $0.1 million in bad debt expense plus a $0.3 million
decrease in deferred income tax benefit, offset by a $0.1 million decrease in share-based
compensation.
Deferred Revenue. Cash from operations benefited from increases in deferred revenue primarily due
to an increase in the volume of implementation and maintenance services invoiced by the NextGen
Division which had not yet been rendered or recognized as revenue. Deferred revenue increased by
approximately $3.2 million for the three months ended June 30, 2011 versus a decrease of $0.2
million in the same prior year period, resulting in a $3.4 million increase to cash from operations
as compared to the same prior year period.
38
Table of Contents
Accounts Receivable. Accounts receivable grew by approximately $9.7 million and $4.9 million for
the three months ended June 30, 2011 and 2010, respectively. The increase in accounts receivable
is due to the following factors:
| NextGen Division revenue grew 19.1% and 19.5% on a year-over-year basis for the three months ended June 30, 2011 and 2010, respectively; | ||
| Inpatient Division revenue grew to $7.3 million for the three months ended June 30, 2011 as compared to $3.2 million for the same prior year period; | ||
| Turnover of accounts receivable is generally slower in the NextGen Division and Inpatient Solutions Division due to the fact that the systems sales related revenue have longer payment terms, generally up to one year, which historically have accounted for a major portion of the Divisions sales; and | ||
| We experienced an increase in the volume of undelivered services billed in advance, which were unpaid as of the end of each period and included in accounts receivable. This resulted in an increase in both deferred revenue and accounts receivable of approximately $3.8 million for the three months ended June 30, 2011 and a decrease of approximately $0.8 million for the three months ended June 30, 2010. |
The turnover of accounts receivable measured in terms of days sales outstanding (DSO) increased
from 123 days to 135 days during the three months ended June 30, 2011 as compared the same prior
year period. The increase in DSO is primarily due to the factors mentioned.
If amounts included in both accounts receivable and deferred revenue were netted, the turnover of
accounts receivable expressed as DSO would be 81 days as of June 30, 2011 and 80 days as of June
30, 2010. Provided turnover of accounts receivable, deferred revenue and profitability remain
consistent with the 2011 fiscal year, we anticipate being able to continue generating cash from
operations during fiscal year 2012 primarily from our net income.
Other Assets and Liabilities. Cash from operations benefited from changes in other assets and
liabilities of $3.0 million and $7.4 million for the three months ended June 30, 2011 and 2010,
respectively. For the three months ended June 30, 2011, the $3.0 million change in other assets
and liabilities is the result of a $4.4 million increase in income taxes payable, offset by a $0.6
million decrease in accounts payable and a $0.8 million net decrease in all other liabilities. For
the three months ended June 30, 2010, the $7.4 million change in other assets and liabilities is
the result of a $2.9 million net increase in other assets, $3.8 million increase in income taxes
payable and $1.2 million increase in accounts payable, offset by a $0.5 million net decrease in all
other liabilities.
Cash Flows from Investing Activities
Net cash used in investing activities for the three months ended June 30, 2011 and 2010 was $8.3
million and $3.4 million, respectively. The $4.9 million increase of net cash used in investing
activities during the three months ended June 30, 2011 as compared to the same prior year period is
primarily due to cash paid for the acquisition of IntraNexus of $3.4 million plus an increase of
$1.5 million in net additions of equipment and improvements in the three months ended June 30, 2011
as compared to the same prior year period.
Cash Flows from Financing Activities
Net cash used in financing activities for the three months ended June 30, 2011 and 2010 was $5.9
million and $7.4 million, respectively. During the three months ended June 30, 2011, we received
proceeds of $3.4 million from the exercise of stock options and paid $10.2 million in dividends to
shareholders compared to proceeds of $1.1 million from the exercise of stock options and payments
of $8.7 million in dividends to shareholders during the same prior year period.
We recorded a reduction in our tax benefit from share-based compensation of $0.9 million and $0.2
million during the three months ended June 30, 2011 and 2010, respectively, related to excess tax
deductions received from stock option exercises. The benefit was recorded as additional paid in
capital.
39
Table of Contents
Cash and Cash Equivalents and Marketable Securities
At June 30, 2011, we had cash and cash equivalents of $124.1 million. We intend to expend some of
these funds for the development of products complementary to our existing product line as well as
new versions of certain of our products. These developments are intended to take advantage of more
powerful technologies and to increase the integration of our products. We also intend to expend
some of these funds related to the implementation of a company-wide enterprise resource planning
(ERP) system. We believe the ERP will greatly enhance and streamline our operational processes
and provide a common technology platform to support future growth opportunities. We anticipate
capital expenditures will increase in fiscal year 2012 and will be funded from cash on hand and
cash flows from operations.
In January 2007, our Board of Directors adopted a policy whereby we intend to pay a regular
quarterly dividend of $0.25 per share on our outstanding common stock, subject to further Board
review and approval and establishment of record and distribution dates by our Board of Directors
prior to the declaration of each such quarterly dividend. Our Board of Directors increased the
quarterly dividend to $0.30 per share in August 2008 and to $0.35 per share in January 2011. We
anticipate that future quarterly dividends, if and when declared by our Board of Directors pursuant
to this policy, would likely be distributable on or about the fifth day of each of the months of
October, January, April and July.
On July 27, 2011, the Board of Directors approved a quarterly cash dividend of $0.35 per share on
the Companys outstanding shares of common stock, payable to shareholders of record as of September
19, 2011 with an expected distribution date on or about October 5, 2011.
Our Board of Directors declared the following dividends during the periods presented:
Per Share | ||||||||
Declaration Date | Record Date | Payment Date | Dividend | |||||
May 25, 2011 |
June 17, 2011 | July 5, 2011 | $ | 0.35 | ||||
Fiscal year 2012 |
$ | 0.35 | ||||||
May 26, 2010 |
June 17, 2010 | July 6, 2010 | $ | 0.30 | ||||
July 28, 2010 |
September 17, 2010 | October 5, 2010 | 0.30 | |||||
October 25, 2010 |
December 17, 2010 | January 5, 2011 | 0.30 | |||||
January 26, 2011 |
March 17, 2011 | April 5, 2011 | 0.35 | |||||
Fiscal year 2011 |
$ | 1.25 | ||||||
May 27, 2009 |
June 12, 2009 | July 6, 2009 | $ | 0.30 | ||||
July 23, 2009 |
September 25, 2009 | October 5, 2009 | 0.30 | |||||
October 28, 2009 |
December 23, 2009 | January 5, 2010 | 0.30 | |||||
January 27, 2010 |
March 23, 2010 | April 5, 2010 | 0.30 | |||||
Fiscal year 2010 |
$ | 1.20 | ||||||
Management believes that its cash and cash equivalents on hand at June 30, 2011, together with its
marketable securities and cash flows from operations, if any, will be sufficient to meet its
working capital and capital expenditure requirements as well as any dividends to be paid in the
ordinary course of business for the remainder of fiscal year 2012.
Contractual Obligations
The following table summarizes our significant contractual obligations, all of which relate to
operating leases, at June 30, 2011 and the effect that such obligations are expected to have on our
liquidity and cash in future periods:
Year ended March 31, | ||||
2012 (remaining nine months) |
$ | 4,095 | ||
2013 |
5,723 | |||
2014 |
5,491 | |||
2015 |
5,008 | |||
2016 and beyond |
5,697 | |||
$ | 26,014 | |||
40
Table of Contents
Recent Accounting Pronouncements
Refer to Note 1, Summary of Significant Accounting Policies, of our notes to consolidated
financial statements included elsewhere in this Report for a discussion of new accounting
standards.
41
Table of Contents
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISKS
We currently maintain our cash in very liquid short term assets including tax exempt and taxable
money market funds and short-term U.S. Treasury securities with maturities of 90 days or less at
the time of purchase.
ITEM 4. CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
Our Chief Executive Officer and Chief Financial Officer (our principal executive officer and
principal financial officer, respectively) have evaluated the effectiveness of the Companys
disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Security
Exchange Act of 1934, as amended) as of June 30, 2011, the end of the period covered by the
Quarterly Report (the Evaluation Date). They have concluded that, as of the Evaluation Date,
these disclosure controls and procedures were effective to ensure that material information
relating to the Company and its consolidated subsidiaries would be made known to them by others
within those entities and would be disclosed on a timely basis. The Chief Executive Officer and
Chief Financial Officer have concluded that the Companys disclosure controls and procedures are
designed, and are effective, to give reasonable assurance that the information required to be
disclosed by the Company in reports that it files under the Exchange Act is recorded, processed,
summarized and reported within the time period specified in the rules and forms of the Securities
and Exchange Commission (SEC). They have also concluded that the Companys disclosure controls
and procedures are effective to ensure that information required to be disclosed in the reports
that are filed or submitted under the Exchange Act are accumulated and communicated to the
Companys management, including the Chief Executive Officer and Chief Financial Officer, to allow
timely decisions regarding required disclosure.
Changes in Internal Control over Financial Reporting
During the quarter ended June 30, 2011, there were no changes in our internal control over
financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) that have materially
affected, or are reasonably likely to materially affect, our internal control over financial
reporting.
The Companys management, including its Chief Executive Officer and Chief Financial Officer, has
concluded that our disclosure controls and procedures and internal control over financial reporting
are designed to provide reasonable assurance of achieving their objectives and are effective at
that reasonable assurance level. However, the Companys management can provide no assurance that
our disclosure controls and procedures or our internal control over financial reporting can prevent
all errors and all fraud under all circumstances. A control system, no matter how well conceived
and operated, can provide only reasonable, not absolute, assurance that the objectives of the
control system are met. Further, the design of a control system must reflect the fact that there
are resource constraints, and the benefits of controls must be considered relative to their costs.
Because of the inherent limitations in all control systems, no evaluation of controls can provide
absolute assurance that all control issues and instances of fraud, if any, within the Company have
been or will be detected. The design of any system of controls also is based in part upon certain
assumptions about the likelihood of future events, and there can be no assurance that any design
will succeed in achieving its stated goals under all potential future conditions; over time,
controls may become inadequate because of changes in conditions, or the degree of compliance with
policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective
control system, misstatements due to error or fraud may occur and not be detected.
42
Table of Contents
PART II. OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
We have experienced legal claims by parties asserting that we have infringed their intellectual
property rights. We believe that these claims are without merit and intend to defend against them
vigorously; however, we could incur substantial costs and diversion of management resources
defending any infringement claim, even if we are ultimately successful in the defense of such
matter. Litigation is inherently uncertain and always difficult to predict. We refer you to the
discussion of infringement and litigation risks in our Item 1A. Risk Factors section of our
Annual Report on Form 10-K for the fiscal year ended March 31, 2011.
ITEM 1A. RISK FACTORS
There have been no material changes during the three months ended June 30, 2011 to the risk factors
disclosed in Item 1A. Risk Factors in our Annual Report on Form 10-K for the fiscal year ended
March 31, 2011.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
None.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
None.
ITEM 4. (REMOVED AND RESERVED)
ITEM 5. OTHER INFORMATION
None.
43
Table of Contents
ITEM 6. EXHIBITS
Exhibit | ||
Number | Description | |
10.1*
|
Second Amendment to Office Lease, dated June 13, 2011, between the Company and Lakeshore Towers Limited Partnership Phase II. | |
31.1*
|
Certification of Principal Executive Officer Required by Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |
31.2*
|
Certification of Principal Financial Officer Required by Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |
32.1*
|
Certification of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | |
101.INS**
|
XBRL Instance | |
101.SCH**
|
XBRL Taxonomy Extension Schema | |
101.CAL**
|
XBRL Taxonomy Extension Calculation | |
101.LAB**
|
XBRL Taxonomy Extension Label | |
101.PRE**
|
XBRL Taxonomy Extension Presentation | |
101.DEF**
|
XBRL Taxonomy Extension Definition |
* | Filed herewith. | |
** | XBRL information is furnished and not filed or a part of a registration statement or prospectus for purposes of section 11 or 12 of the Securities and Exchange Act of 1933, as amended, is deemed not filed for purposes of section 18 of the Securities and Exchange Act of 1934, as amended, and otherwise is not subject to liability under these section. |
44
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the undersigned thereunto duly authorized.
QUALITY SYSTEMS, INC.
Date: August 5, 2011
|
By: | /s/ Steven T. Plochocki
|
||||
Chief Executive Officer (Principal Executive Officer) | ||||||
Date: August 5, 2011
|
By: | /s/ Paul A. Holt
|
||||
Chief Financial Officer (Principal Accounting Officer) |
45